Code | Display | Comments |
---|
1-8 | Acyclovir [Susceptibility] | | |
10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer | | |
100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit | | |
100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | | |
100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | | |
100041-3 | Aminoglycoside [Susceptibility] | | |
100042-1 | Atovaquone [Susceptibility] | | |
100043-9 | Azithromycin+Ethambutol [Susceptibility] | | |
100044-7 | Cefcapene [Susceptibility] | | |
100045-4 | Cefozopran [Susceptibility] | | |
100046-2 | Cefquinome [Susceptibility] | | |
100047-0 | Cefteram [Susceptibility] | | |
100048-8 | Clarithromycin+Ethambutol [Susceptibility] | | |
100049-6 | Eravacycline [Susceptibility] | | |
100050-4 | Erythromycin+Ethambutol [Susceptibility] | | |
100051-2 | Ethambutol+rifAMPin [Susceptibility] | | |
100052-0 | Flomoxef [Susceptibility] | | |
100053-8 | Fluoroquinolone [Susceptibility] | | |
100054-6 | Gamithromycin [Susceptibility] | | |
100055-3 | Optochin [Susceptibility] | | |
100056-1 | Panipenem [Susceptibility] | | |
100057-9 | Prothionamide [Susceptibility] | | |
100058-7 | Prulifloxacin [Susceptibility] | | |
100059-5 | Rifapentine [Susceptibility] | | |
100060-3 | Tildipirosin [Susceptibility] | | |
100061-1 | Tosufloxacin [Susceptibility] | | |
100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | | |
100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot | | |
100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | | |
100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | | |
100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | | |
100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | | |
100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | | |
100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | | |
100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | | |
100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | | |
100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | | |
100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | | |
100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | | |
1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor | | |
100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | | |
100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | | |
100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | | |
100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | | |
100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | | |
100105-6 | Filaria IgG and IgM panel - Serum | | |
100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay | | |
100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | | |
100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | | |
100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot | | |
100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | | |
100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | | |
100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot | | |
100113-0 | Helicobacter pylori Ab panel - Serum | | |
100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | | |
100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | | |
100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | | |
100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | | |
100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | | |
100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | | |
100120-5 | Chlamydia trachomatis Ab panel - Serum | | |
100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | | |
100122-1 | Chlamydophila pneumoniae Ab panel - Serum | | |
100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | | |
100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | | |
100125-4 | Chlamydophila psittaci Ab panel - Serum | | |
100126-2 | Bordetella pertussis Ab.IgG panel - Serum | | |
100127-0 | Campylobacter sp Ab panel - Serum | | |
100128-8 | Cryptococcus sp Ag panel - Serum | | |
100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | | |
100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | | |
100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | | |
100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | | |
100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | | |
100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | | |
100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | | |
100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | | |
100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | | |
100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | | |
100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | | |
100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | | |
100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | | |
100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | | |
100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | | |
100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | | |
100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | | |
100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | | |
100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | | |
100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot | | |
100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | | |
100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | | |
100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | | |
100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | | |
100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | | |
100154-4 | Specimen collection supervision level | | |
100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | | |
100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | | |
100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration | | |
1002-5 | DBG Ab [Presence] in Serum or Plasma | | |
100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method | | |
100281-5 | D Ab [Units/volume] in Serum or Plasma | | |
1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | | |
100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | | |
100306-0 | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | | |
100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF | | |
100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | | |
100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | | |
100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | | |
100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | | |
100346-6 | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG | | |
100347-4 | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG | | |
100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum | | |
100351-6 | Pioglitazone [Presence] in Serum or Plasma | | |
100352-4 | Rosiglitazone [Presence] in Serum or Plasma | | |
100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | | |
100357-3 | Naloxone [Presence] in Cord tissue by Screen method | | |
100358-1 | Phentermine [Presence] in Cord tissue by Screen method | | |
100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay | | |
100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS | | |
100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | | |
100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay | | |
100372-2 | Abiraterone [Mass/volume] in Serum or Plasma | | |
100373-0 | Eucheuma IgG Ab [Units/volume] in Serum | | |
100374-8 | Aloe vera IgG Ab [Units/volume] in Serum | | |
100375-5 | Anise IgG Ab [Units/volume] in Serum | | |
100376-3 | Bambusa vulgaris IgG Ab [Units/volume] in Serum | | |
100377-1 | Goat cheese IgG Ab [Units/volume] in Serum | | |
100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum | | |
100379-7 | Leeks IgG Ab [Units/volume] in Serum | | |
100380-5 | Red cabbage IgG Ab [Units/volume] in Serum | | |
100381-3 | Mentha balsamea Wild IgG Ab [Units/volume] in Serum | | |
100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
100384-7 | Rapeseed IgG Ab [Units/volume] in Serum | | |
100385-4 | Corn salad IgG Ab [Units/volume] in Serum | | |
100386-2 | Rosemary IgG Ab [Units/volume] in Serum | | |
100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum | | |
100388-8 | Cocoa IgG Ab [Units/volume] in Serum | | |
100389-6 | Pistachio IgG Ab [Units/volume] in Serum | | |
100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum | | |
100391-2 | Dates IgG Ab [Units/volume] in Serum | | |
100392-0 | Duck meat IgG Ab [Units/volume] in Serum | | |
100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | | |
100394-6 | Astacoidea IgG Ab [Units/volume] in Serum | | |
100395-3 | Carob IgG Ab [Units/volume] in Serum | | |
100396-1 | Brassica napus IgG Ab [Units/volume] in Serum | | |
100397-9 | Goat Meat IgG Ab [Units/volume] in Serum | | |
100398-7 | Goose meat IgG Ab [Units/volume] in Serum | | |
100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum | | |
1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | | |
100400-1 | Quail meat IgG Ab [Units/volume] in Serum | | |
100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum | | |
100402-7 | Venison meat IgG Ab [Units/volume] in Serum | | |
100403-5 | Guineafowl IgG Ab [Units/volume] in Serum | | |
100404-3 | Horse meat IgG Ab [Units/volume] in Serum | | |
100405-0 | Kefir IgG Ab [Units/volume] in Serum | | |
100406-8 | Butter IgG Ab [Units/volume] in Serum | | |
100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum | | |
100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum | | |
100409-2 | Processed cheese IgG Ab [Units/volume] in Serum | | |
100410-0 | Curd cheese IgG Ab [Units/volume] in Serum | | |
100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum | | |
100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum | | |
100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum | | |
100414-2 | Gourd IgG Ab [Units/volume] in Serum | | |
100415-9 | Kale IgG Ab [Units/volume] in Serum | | |
100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum | | |
100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum | | |
100418-3 | Liquorice IgG Ab [Units/volume] in Serum | | |
100419-1 | Snow pea IgG Ab [Units/volume] in Serum | | |
100420-9 | Fava bean IgG Ab [Units/volume] in Serum | | |
100421-7 | Chick Pea IgG Ab [Units/volume] in Serum | | |
100422-5 | Chicory IgG Ab [Units/volume] in Serum | | |
100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum | | |
100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma | | |
100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma | | |
100426-6 | Squalene [Mass/volume] in Serum or Plasma | | |
100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma | | |
100428-2 | Carnitine free and total and acylcarnitine panel - Urine | | |
100429-0 | LRBA deficiency panel - Blood | | |
100430-8 | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) | | |
100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | | |
100432-4 | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | | |
100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | | |
100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | | |
100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay | | |
100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | | |
100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method | | |
1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | | |
1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | | |
100654-3 | Pyruvate kinase M2 [Presence] in Stool | | |
100662-6 | Cortisol free and total panel - Serum or Plasma | | |
100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method | | |
100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method | | |
100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method | | |
100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method | | |
100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method | | |
100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method | | |
100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method | | |
100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus | | |
100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection | | |
100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection | | |
100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection | | |
100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | | |
100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | | |
100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | | |
100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | | |
100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | | |
100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection | | |
100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection | | |
100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | | |
100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | | |
100693-1 | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection | | |
100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method | | |
100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative | | |
100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal | | |
100699-8 | Rifabutin+Ethambutol [Susceptibility] | | |
1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | | |
100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection | | |
100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection | | |
100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection | | |
100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection | | |
100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection | | |
100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection | | |
100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection | | |
100707-9 | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count | | |
100708-7 | Plasma cells/100 leukocytes in Synovial fluid | | |
100709-5 | Hepatocellular carcinoma risk [Score] by GAAD | | |
100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection | | |
100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay | | |
100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma | | |
100713-7 | Cariprazine [Mass/volume] in Serum or Plasma | | |
100714-5 | Guanfacine [Mass/volume] in Serum or Plasma | | |
100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma | | |
100716-0 | Prostate specific Ag [Mass/volume] in DBS | | |
100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method | | |
100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum | | |
100733-5 | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) | | |
100734-3 | traMADol and Metabolites Panel - Urine by Confirmatory method | | |
100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes | | |
100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document | | |
100737-6 | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma | | |
100738-4 | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma | | |
100739-2 | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma | | |
100740-0 | Amylase.macromolecular [Presence] in Serum or Plasma | | |
100741-8 | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma | | |
100742-6 | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma | | |
100743-4 | Lipase.macromolecular [Presence] in Serum or Plasma | | |
100744-2 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis | | |
100745-9 | Chloride [Moles/volume] in Mixed venous blood | | |
100746-7 | Glucose [Moles/volume] in Mixed venous blood | | |
100747-5 | Legionella serogroup panel - Specimen | | |
100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection | | |
100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection | | |
100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection | | |
100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma | | |
100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing | | |
100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | | |
100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing | | |
100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing | | |
100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | | |
100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method | | |
100763-2 | Mycobacterium sp comparative reaction interpretation Narrative | | |
100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal | | |
100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS | | |
100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum | | |
100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | | |
100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum | | |
100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum | | |
100792-1 | Forsythia IgE Ab [Units/volume] in Serum | | |
100793-9 | Testosterone [Mass/volume] in Body fluid | | |
100794-7 | Follitropin [Units/volume] in Body fluid | | |
100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid | | |
100796-2 | Thyroglobulin [Mass/volume] in Body fluid | | |
100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge | | |
100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge | | |
100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | | |
1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | | |
100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge | | |
100801-0 | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge | | |
100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge | | |
100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | | |
100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge | | |
100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | | |
100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge | | |
100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | | |
100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge | | |
100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | | |
100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge | | |
100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | | |
100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge | | |
100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | | |
100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge | | |
100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | | |
100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | | |
100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | | |
100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge | | |
100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | | |
100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge | | |
100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge | | |
100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge | | |
100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | | |
100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | | |
100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | | |
100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | | |
100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | | |
100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | | |
100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | | |
100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | | |
100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma | | |
100840-8 | IgE [Units/volume] in Body fluid | | |
100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot | | |
100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST | | |
100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ | | |
100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 | | |
100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) | | |
100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | | |
100847-3 | Gas and ammonia panel - Arterial blood | | |
100848-1 | Cell count and Differential panel - Amniotic fluid by Manual count | | |
100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count | | |
100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count | | |
100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count | | |
100854-9 | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay | | |
100855-6 | CD3 cells/100 cells in Blood mononuclear cells | | |
100856-4 | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells | | |
100857-2 | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells | | |
100858-0 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | | |
100861-4 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | | |
100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method | | |
100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection | | |
100866-3 | Febrile antibody profile in Serum | | |
100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay | | |
100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method | | |
100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method | | |
100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method | | |
100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method | | |
100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate | | |
100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method | | |
100874-7 | Basidiobolus sp [Presence] in Specimen | | |
100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection | | |
100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection | | |
100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection | | |
100888-7 | West African monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
100889-5 | Congo Basin monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | | |
100890-3 | Poxvirus DNA panel | | |
100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | | |
100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | | |
100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | | |
100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum | | |
100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | | |
100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture | | |
100898-6 | Lipid panel - Serum or Plasma | | |
100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture | | |
1009-0 | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | | |
100900-0 | Enterobacteriaceae.carbapenem resistance panel - Anal by Organism specific culture | | |
100901-8 | Enterobacteriaceae.carbapenemase resistance phenotype [Identifier] in Anal by Organism specific culture | | |
100902-6 | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 [Identifier] in Anal by Organism specific culture | | |
100903-4 | Yeast and Candida sp identification panel - Specimen by Organism specific culture | | |
100904-2 | Urinary tract pathogens panel - Urine by Culture | | |
100905-9 | Gram positive bacteria identified in Isolate by Organism specific culture | | |
100906-7 | Bacteria [#/volume] in Urine by Culture | | |
100907-5 | Vancomycin resistant enterococcus [Identifier] in Specimen by Organism specific culture | | |
100908-3 | Pseudomonas aeruginosa [Presence] in Lower respiratory specimen by Organism specific culture | | |
100909-1 | Cronobacter sakazakii [Presence] by Organism specific culture | | |
100910-9 | Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture | | |
100911-7 | Campylobacter sp [Presence] in Stool by Organism specific culture | | |
100912-5 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel | | |
100913-3 | Staph aureus and MRSA screening panel - Specimen by Organism specific culture | | |
100914-1 | Protein.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis | | |
100915-8 | Burr cells [Presence] in Body fluid by Light microscopy | | |
100962-0 | Dengue virus Ab.IgG Panel - Serum, Plasma or Blood | | |
100963-8 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | | |
100964-6 | Dengue virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | | |
100965-3 | Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood | | |
100968-7 | Bovine tuberculosis comparative cervical test panel - Skin | | |
101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) | | |
1010-8 | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit | | |
1011-6 | E sup(w) Ab [Presence] in Serum or Plasma from Donor | | |
1012-4 | E sup(w) Ab [Presence] in Serum or Plasma | | |
1013-2 | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit | | |
1014-0 | E sup(w) Ag [Presence] on Red Blood Cells from Donor | | |
1015-7 | E sup(w) Ag [Presence] on Red Blood Cells | | |
1016-5 | E Ab [Presence] in Serum or Plasma from Blood product unit | | |
1017-3 | E Ab [Presence] in Serum or Plasma from Donor | | |
1018-1 | E Ab [Presence] in Serum or Plasma | | |
1019-9 | E Ag [Presence] on Red Blood Cells from Blood product unit | | |
102-4 | Cefoperazone [Susceptibility] by Serum bactericidal titer | | |
1020-7 | E Ag [Presence] on Red Blood Cells from Donor | | |
1021-5 | E Ag [Presence] on Red Blood Cells | | |
1022-3 | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | | |
10226-9 | Oxygen content in Intravascular space | | |
1023-1 | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor | | |
10232-7 | Oxygen content in Aorta root | | |
10233-5 | Oxygen content in Left atrium | | |
10234-3 | Oxygen content in Right atrium | | |
10235-0 | Oxygen content in High right atrium | | |
10236-8 | Oxygen content in Low right atrium | | |
10237-6 | Oxygen content in Mid right atrium | | |
10238-4 | Oxygen content in Left ventricle | | |
10239-2 | Oxygen content in Right ventricular outflow tract | | |
1024-9 | Fy sup(a) Ab [Presence] in Serum or Plasma | | |
10240-0 | Oxygen content in Right ventricle | | |
10241-8 | Oxygen content in Coronary sinus | | |
10242-6 | Oxygen content in Ductus arteriosus | | |
10243-4 | Oxygen content in Inferior vena cava | | |
10244-2 | Oxygen content in Left pulmonary artery | | |
10245-9 | Oxygen content in Main pulmonary artery | | |
10246-7 | Oxygen content in Right pulmonary artery | | |
10247-5 | Oxygen content in Pulmonary wedge | | |
10248-3 | Oxygen content in Superior vena cava | | |
1025-6 | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | | |
1026-4 | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor | | |
1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells | | |
1028-0 | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | | |
1029-8 | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor | | |
103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) | | |
1030-6 | Fy sup(b) Ab [Presence] in Serum or Plasma | | |
1031-4 | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | | |
1032-2 | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor | | |
10327-5 | Eosinophils/100 leukocytes in Sputum by Manual count | | |
10328-3 | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count | | |
10329-1 | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count | | |
1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells | | |
10330-9 | Monocytes/100 leukocytes in Body fluid by Manual count | | |
10331-7 | Rh [Type] in Blood | | |
10332-5 | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM | | |
10333-3 | Appearance of Cerebral spinal fluid | | |
10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma | | |
10335-8 | Color of Cerebral spinal fluid | | |
10336-6 | Gonadotropin peptide [Mass/volume] in Urine | | |
10337-4 | Procollagen type I [Mass/volume] in Serum | | |
10338-2 | Barbiturates [Mass/volume] in Serum or Plasma | | |
10339-0 | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | | |
1034-8 | Fetal cell screen [Interpretation] in Blood | | |
10340-8 | Molindone [Mass/volume] in Serum or Plasma | | |
10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma | | |
10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma | | |
10343-2 | Temazepam [Mass/volume] in Serum or Plasma | | |
10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma | | |
10345-7 | Trihexyphenidyl [Mass/volume] in Urine | | |
10346-5 | Hemoglobin A [Units/volume] in Blood by Electrophoresis | | |
10347-3 | Babesia microti identified in Blood by Light microscopy | | |
10348-1 | Bordetella parapertussis Ab [Presence] in Serum | | |
10349-9 | Brucella sp Ab [Units/volume] in Serum | | |
1035-5 | Fresh frozen plasma given [Volume] | | |
10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay | | |
10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | | |
10352-3 | Bacteria identified in Genital specimen by Aerobe culture | | |
10353-1 | Bacteria identified in Nose by Aerobe culture | | |
10354-9 | Bacteria identified in Urethra by Culture | | |
10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain | | |
10356-4 | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain | | |
10357-2 | Microscopic observation [Identifier] in Wound by Gram stain | | |
10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) | | |
10359-8 | Asialoganglioside GM1 IgM Ab [Titer] in Serum | | |
1036-3 | G Ab [Presence] in Serum or Plasma from Blood product unit | | |
10360-6 | DNA single strand IgG Ab [Units/volume] in Serum | | |
10361-4 | DNA single strand IgM Ab [Units/volume] in Serum | | |
10362-2 | Endomysium IgA Ab [Presence] in Serum | | |
10363-0 | Barbiturates [Presence] in Specimen | | |
10364-8 | Cotinine [Mass/mass] in Hair | | |
10365-5 | Cotinine [Mass/volume] in Serum or Plasma | | |
10366-3 | Cotinine [Mass/volume] in Urine | | |
10367-1 | Ethanol [Mass/volume] in Gastric fluid | | |
10368-9 | Lead [Mass/volume] in Capillary blood | | |
10369-7 | Opiates [Mass/mass] in Hair | | |
1037-1 | G Ab [Presence] in Serum or Plasma from Donor | | |
10370-5 | Phencyclidine [Mass/mass] in Hair | | |
10371-3 | Bite cells [Presence] in Blood by Light microscopy | | |
10372-1 | Blister cells [Presence] in Blood by Light microscopy | | |
10373-9 | Fragments [Presence] in Blood by Light microscopy | | |
10374-7 | Helmet cells [Presence] in Blood by Light microscopy | | |
10375-4 | Irregularly contracted cells [Presence] in Blood by Light microscopy | | |
10376-2 | Oval macrocytes [Presence] in Blood by Light microscopy | | |
10377-0 | Pencil cells [Presence] in Blood by Light microscopy | | |
10378-8 | Polychromasia [Presence] in Blood by Light microscopy | | |
10379-6 | Erythrocytes.dual population [Presence] in Blood by Light microscopy | | |
1038-9 | G Ab [Presence] in Serum or Plasma | | |
10380-4 | Stomatocytes [Presence] in Blood by Light microscopy | | |
10381-2 | Target cells [Presence] in Blood by Light microscopy | | |
10382-0 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit | | |
10383-8 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Donor | | |
10384-6 | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells | | |
10385-3 | Albumin concentration given | | |
10386-1 | Albumin given [Volume] | | |
10387-9 | Autologous erythrocytes given [Volume] | | |
10388-7 | Autologous whole blood given [Volume] | | |
10389-5 | Blood product.other [Type] | | |
1039-7 | G Ag [Presence] on Red Blood Cells from Blood product unit | | |
10390-3 | Blood product special preparation [Type] | | |
10391-1 | Cytomegalovirus immune globulin given [Volume] | | |
10392-9 | Cryoprecipitate given [Volume] | | |
10393-7 | Factor IX given [Type] | | |
10394-5 | Factor IX given [Volume] | | |
10395-2 | Factor VIII given [Type] | | |
10396-0 | Factor VIII given [Volume] | | |
10397-8 | Hepatitis B immune globulin given [Volume] | | |
10398-6 | I Ag [Presence] on Red Blood Cells from Blood product unit | | |
10399-4 | I Ag [Presence] on Red Blood Cells from Donor | | |
104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
1040-5 | G Ag [Presence] on Red Blood Cells from Donor | | |
10400-0 | I Ag [Presence] on Red Blood Cells | | |
10401-8 | Immune serum globulin given [Type] | | |
10402-6 | Immune serum globulin given [Volume] | | |
10403-4 | Inject immune serum globulin [Volume] | | |
10404-2 | Inject Rh immune globulin [Volume] | | |
10405-9 | Inject varicella zoster virus immune globulin [Volume] | | |
10406-7 | little i Ag [Presence] on Red Blood Cells from Blood product unit | | |
10407-5 | little i Ag [Presence] on Red Blood Cells from Donor | | |
10408-3 | little i Ag [Presence] on Red Blood Cells | | |
10409-1 | Pentaspan given [Volume] | | |
1041-3 | G Ag [Presence] on Red Blood Cells | | |
10410-9 | Plasma given [Type] | | |
10411-7 | Plasma given [Volume] | | |
10412-5 | Platelets given [Type] | | |
10413-3 | Rh immune globulin given [Volume] | | |
10414-1 | Transfuse albumin [Volume] | | |
10415-8 | Transfuse blood exchange transfusion [Volume] | | |
10416-6 | Transfuse blood product other [Volume] | | |
10417-4 | Transfuse cryoprecipitate [Volume] | | |
10418-2 | Transfuse factor IX [Volume] | | |
10419-0 | Transfuse factor VIII [Volume] | | |
1042-1 | H Ab [Presence] in Serum or Plasma from Blood product unit | | |
10420-8 | Transfuse immune serum globulin [Volume] | | |
10421-6 | Transfuse Pentaspan [Volume] | | |
10422-4 | Transfuse plasma [Volume] | | |
10423-2 | Transfuse platelets [Volume] | | |
10424-0 | Transfuse erythrocytes [Volume] | | |
10425-7 | Transfuse Rh immune globulin [Volume] | | |
10426-5 | Transfuse whole blood [Volume] | | |
10427-3 | Transfuse whole blood autologous [Volume] | | |
10428-1 | Varicella zoster virus immune globulin given [Volume] | | |
10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain | | |
1043-9 | H Ab [Presence] in Serum or Plasma from Donor | | |
10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain | | |
10431-5 | B-cell Ag [Presence] in Tissue by Immune stain | | |
10432-3 | CD30 Ag [Presence] in Tissue by Immune stain | | |
10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain | | |
10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain | | |
10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain | | |
10436-4 | CD15 Ag [Presence] in Tissue by Immune stain | | |
10437-2 | CD16 Ag [Presence] in Tissue by Immune stain | | |
10438-0 | CD20 Ag [Presence] in Tissue by Immune stain | | |
10439-8 | CD3 Ag [Presence] in Tissue by Immune stain | | |
1044-7 | H Ab [Presence] in Serum | | |
10440-6 | Deprecated CD30 Ag [Presence] in Tissue by Immune stain | | |
10441-4 | CD34 Ag [Presence] in Tissue by Immune stain | | |
10442-2 | CD56 Ag [Presence] in Tissue by Immune stain | | |
10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain | | |
10444-8 | CD57 Ag [Presence] in Tissue by Immune stain | | |
10445-5 | CD11c Ag [Presence] in Tissue by Immune stain | | |
10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain | | |
10447-1 | M-5 Ag [Presence] in Tissue by Immune stain | | |
10448-9 | T-cell Ag [Presence] in Tissue by Immune stain | | |
10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal | | |
1045-4 | Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unit | | |
10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting | | |
10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting | | |
10452-1 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO | | |
10453-9 | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO | | |
10454-7 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO | | |
10455-4 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO | | |
10456-2 | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting | | |
10457-0 | Actin Ag [Presence] in Tissue by Immune stain | | |
10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain | | |
10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain | | |
1046-2 | Deprecated H NOS Ab [Presence] in Serum or Plasma from Donor | | |
10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain | | |
10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain | | |
10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain | | |
10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain | | |
10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain | | |
10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain | | |
10466-1 | Anion gap 3 in Serum or Plasma | | |
10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain | | |
10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain | | |
10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain | | |
1047-0 | Deprecated H NOS Ab [Presence] in Serum or Plasma | | |
10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain | | |
10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain | | |
10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain | | |
10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain | | |
10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain | | |
10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain | | |
10476-0 | Desmin Ag [Presence] in Tissue by Immune stain | | |
10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain | | |
10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain | | |
10479-4 | CD227 Ag [Presence] in Tissue by Immune stain | | |
1048-8 | Deprecated H NOS Ag [Presence] on Red Blood Cells from Blood product unit | | |
10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain | | |
10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain | | |
10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain | | |
10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain | | |
10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain | | |
10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain | | |
10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain | | |
10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain | | |
10488-5 | IgA Ag [Presence] in Tissue by Immune stain | | |
10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain | | |
1049-6 | Deprecated H NOS Ag [Presence] on Red Blood Cells from Donor | | |
10490-1 | IgE Ag [Presence] in Tissue by Immune stain | | |
10491-9 | IgG Ag [Presence] in Tissue by Immune stain | | |
10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain | | |
10493-5 | IgM Ag [Presence] in Tissue by Immune stain | | |
10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain | | |
10495-0 | Insulin Ag [Presence] in Tissue by Immune stain | | |
10496-8 | Kappa light chains Ag [Presence] in Tissue by Immune stain | | |
10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain | | |
10498-4 | Keratin Ag [Presence] in Tissue by Immune stain | | |
10499-2 | Lambda light chains Ag [Presence] in Tissue by Immune stain | | |
105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) | | |
1050-4 | Deprecated H NOS Ag [Presence] on Red Blood Cells | | |
10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain | | |
10501-5 | Lutropin [Units/volume] in Serum or Plasma | | |
10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain | | |
10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain | | |
10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain | | |
10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain | | |
10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain | | |
10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain | | |
10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain | | |
10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain | | |
1051-2 | Hemolytic disease of newborn screen [Interpretation] in Blood | | |
10510-6 | S-100 Ag [Presence] in Tissue by Immune stain | | |
10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain | | |
10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain | | |
10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain | | |
10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain | | |
10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain | | |
10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain | | |
10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain | | |
10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain | | |
10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain | | |
1052-0 | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit | | |
10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain | | |
10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain | | |
10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain | | |
10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain | | |
10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain | | |
10525-4 | Microscopic observation [Identifier] in Specimen by Cyto stain | | |
10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain | | |
10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain | | |
10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma | | |
10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma | | |
1053-8 | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor | | |
10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma | | |
10531-2 | Bretylium [Mass/volume] in Serum or Plasma | | |
10532-0 | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma | | |
10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma | | |
10534-6 | Diazoxide [Mass/volume] in Serum or Plasma | | |
10535-3 | Digoxin [Mass/volume] in Serum or Plasma | | |
10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma | | |
10537-9 | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | | |
10538-7 | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | | |
10539-5 | glipiZIDE [Mass/volume] in Serum or Plasma | | |
1054-6 | Deprecated I (intermediate) subtype [Presence] in srum | | |
10540-3 | glyBURIDE [Mass/volume] in Serum or Plasma | | |
10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma | | |
10542-9 | Metharbital [Mass/volume] in Serum or Plasma | | |
10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma | | |
10544-5 | Normeperidine [Presence] in Serum or Plasma | | |
10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma | | |
10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma | | |
10547-8 | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma | | |
10548-6 | Phenytoin Free/Phenytoin.total in Serum or Plasma | | |
10549-4 | Pirmenol [Mass/volume] in Serum or Plasma | | |
1055-3 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit | | |
10550-2 | Deprecated Temazepam [Mass/volume] in Serum or Plasma | | |
10551-0 | Triamterene [Mass/volume] in Serum or Plasma | | |
10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma | | |
10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid | | |
10554-4 | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma | | |
10555-1 | Acrosin [Entitic Catalytic Activity] in Spermatozoa | | |
10556-9 | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma | | |
10557-7 | Adenosine triphosphate [Moles/volume] in Semen | | |
10558-5 | Albumin [Moles/volume] in Semen | | |
10559-3 | Deprecated Calcium [Molecules/volume] in Semen | | |
1056-1 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor | | |
10560-1 | Carcinoembryonic Ag [Units/volume] in Semen | | |
10561-9 | Carnitine [Moles/volume] in Semen | | |
10562-7 | Cells [#/volume] in Cervical mucus | | |
10563-5 | Cells other than spermatozoa [#/volume] in Semen | | |
10564-3 | Cervical mucus [Volume] | | |
10565-0 | Choriogonadotropin [Units/volume] in Semen | | |
10566-8 | Deprecated Choriogonadotropin [Molecules/volume] in Semen | | |
10567-6 | Citrate [Moles/volume] in Semen | | |
10568-4 | Clarity of Semen | | |
10569-2 | Color of Semen | | |
1057-9 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells | | |
10570-0 | Consistency of Cervical mucus | | |
10571-8 | Deprecated Consistency of Semen | | |
10572-6 | Deprecated Duration^post ejaculation | | |
10573-4 | Ferning [Type] in Cervical mucus | | |
10574-2 | Fructose [Moles/volume] in Semen | | |
10575-9 | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen | | |
10576-7 | Germ cells.immature [#/volume] in Semen | | |
10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma | | |
10578-3 | Glycerophosphocholine [Moles/volume] in Seminal plasma | | |
10579-1 | Leukocytes [#/volume] in Semen | | |
1058-7 | I Ab [Presence] in Serum or Plasma from Blood product unit | | |
10580-9 | Liquefaction [Time] in Semen | | |
10581-7 | Deprecated Number of entities [#] in Spermatozoa | | |
10582-5 | pH of Cervical mucus | | |
10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen | | |
10584-1 | Deprecated Protein [Mass/volume] in Semen | | |
10585-8 | Round cells [#/volume] in Semen | | |
10586-6 | Deprecated Volume of Semen | | |
10587-4 | Sexual abstinence duration | | |
10588-2 | Spermatogonia [#/volume] in Semen | | |
10589-0 | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) | | |
1059-5 | I Ab [Presence] in Serum or Plasma from Donor | | |
10590-8 | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) | | |
10591-6 | Primary Spermatocytes [#/volume] in Semen | | |
10592-4 | Secondary Spermatocytes [#/volume] in Semen | | |
10593-2 | Spermatozoa Pyriform Head/100 spermatozoa in Semen | | |
10594-0 | Spermatozoa Tapering Head/100 spermatozoa in Semen | | |
10595-7 | Deprecated Spermatozoa [#/volume] in Semen | | |
10596-5 | Deprecated Spermatozoa Ab in cervical mucosa | | |
10597-3 | Deprecated Spermatozoa Ab in semen | | |
10598-1 | Deprecated Spermatozoa Ab in serum | | |
10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test | | |
106-5 | Ceforanide [Susceptibility] by Serum bactericidal titer | | |
1060-3 | I Ab [Presence] in Serum or Plasma | | |
10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa | | |
10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus | | |
10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen | | |
10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen | | |
10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen | | |
10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen | | |
10606-2 | Spermatozoa Amorphous Head/100 spermatozoa in Semen | | |
10607-0 | Spermatozoa Coiled Tail/100 spermatozoa in Semen | | |
10608-8 | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen | | |
10609-6 | Spermatozoa Duplicate Head/100 spermatozoa in Semen | | |
1061-1 | Deprecated I NOS Ab [Presence] in Serum or Plasma from Blood product unit | | |
10610-4 | Spermatozoa Duplicate Tail/100 spermatozoa in Semen | | |
10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen | | |
10612-0 | Spermatozoa Large Oval Head/100 spermatozoa in Semen | | |
10613-8 | Spermatozoa Viable/100 spermatozoa in Semen | | |
10614-6 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead | | |
10615-3 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction | | |
10616-1 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead | | |
10617-9 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction | | |
10618-7 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead | | |
10619-5 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction | | |
1062-9 | Deprecated I NOS Ab [Presence] in Serum or Plasma from Donor | | |
10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen | | |
10621-1 | Spermatozoa Normal Head/100 spermatozoa in Semen | | |
10622-9 | Spermatozoa Normal/100 spermatozoa in Semen | | |
10623-7 | Spermatozoa Pin Head/100 spermatozoa in Semen | | |
10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen | | |
10625-2 | Spermatozoa Round Head/100 spermatozoa in Semen | | |
10626-0 | Spermatozoa Slow/100 spermatozoa in Semen | | |
10627-8 | Spermatozoa Small Oval Head/100 spermatozoa in Semen | | |
10628-6 | Spermatozoa Tail Swelling/100 spermatozoa in Semen | | |
10629-4 | Spermatozoa Vacuolated Head/100 spermatozoa in Semen | | |
1063-7 | Deprecated I NOS Ab [Presence] in Serum or Plasma | | |
10630-2 | Spinnbarkeit [Length] in Cervical mucus | | |
10631-0 | Testosterone [Moles/volume] in Semen | | |
10632-8 | Time until next menstrual period | | |
10633-6 | Zinc [Moles/volume] in Semen | | |
10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma | | |
10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture | | |
10636-9 | Acanthamoeba sp identified in Eye by Wet preparation | | |
10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain | | |
10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture | | |
10639-3 | Thermophilic Actinomycetes identified in Specimen by Organism specific culture | | |
1064-5 | Deprecated I NOS Ag [Presence] on Red Blood Cells from Blood product unit | | |
10640-1 | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy | | |
10641-9 | Amoeba identified in Aspirate by Immune stain | | |
10642-7 | Amoeba identified in Aspirate by Wet preparation | | |
10643-5 | Amoeba identified in Stool by Organism specific culture | | |
10644-3 | Arthropod identified in Specimen | | |
10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence | | |
10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy | | |
10647-6 | Babesia sp identified in Blood by Thick film | | |
10648-4 | Babesia sp identified in Blood by Thin film | | |
10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy | | |
1065-2 | Deprecated I NOS Ag [Presence] on Red Blood Cells from Donor | | |
10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification | | |
10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial | | |
10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification | | |
10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) | | |
10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain | | |
10656-7 | Coccidia identified in Stool by Acid fast stain | | |
10657-5 | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence | | |
10658-3 | Cyanobacterium identified in Water by Light microscopy | | |
10659-1 | Cyclospora sp identified in Stool by Acid fast stain | | |
1066-0 | Deprecated I NOS Ag [Presence] on Red Blood Cells | | |
10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain | | |
10661-7 | Dinoflagellate identified in Water by Light microscopy | | |
10662-5 | Filaria identified in Blood by Concentration | | |
10663-3 | Filaria identified in Blood by Thick film | | |
10664-1 | Filaria identified in Blood by Thin film | | |
10665-8 | Fungus colony count [#/volume] in Specimen by Environmental culture | | |
10666-6 | Fungus identified in Tissue by Fontana-Masson stain | | |
10667-4 | Fungus identified in Specimen by Animal inoculation | | |
10668-2 | Fungus identified in Specimen by Environmental culture | | |
10669-0 | Fungus identified in Specimen by Sticky tape for environmental fungus | | |
1067-8 | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | | |
10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture | | |
10671-6 | Helminth identified in Specimen | | |
10672-4 | Helminth+Arthropod identified in Specimen | | |
10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain | | |
10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain | | |
10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain | | |
10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | | |
10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain | | |
10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain | | |
10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain | | |
1068-6 | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor | | |
10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy | | |
10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy | | |
10682-3 | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification | | |
10683-1 | Hydatid cyst identified in Aspirate by Immune stain | | |
10684-9 | Hydatid cyst identified in Liver by Wet preparation | | |
10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation | | |
10686-4 | Leishmania sp identified in Tissue by Giemsa stain | | |
10687-2 | Leishmania sp identified in Tissue by Organism specific culture | | |
10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation | | |
10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation | | |
1069-4 | Jk sup(a) Ab [Presence] in Serum or Plasma | | |
10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified | | |
10691-4 | Mushroom.toxic identified by Inspection | | |
10692-2 | Mushroom.toxic identified in Food by Light microscopy | | |
10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy | | |
10694-8 | Naegleria sp identified in Tissue by Organism specific culture | | |
10695-5 | Naegleria sp identified in Tissue by Wet preparation | | |
10696-3 | Norovirus [Identifier] in Stool by Electron microscopy | | |
10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | | |
10699-7 | Onchocerca sp identified in Tissue by Wet preparation | | |
107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | | |
1070-2 | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | | |
10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy | | |
10701-1 | Ova and parasites identified in Stool by Concentration | | |
10702-9 | Ova and parasites identified in Stool by Immune stain | | |
10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain | | |
10704-5 | Ova and parasites identified in Stool by Light microscopy | | |
10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain | | |
10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy | | |
10707-8 | Toxic Plant identified in Plant specimen by Inspection | | |
10708-6 | Toxic Plant identified in Vomitus by Light microscopy | | |
10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence | | |
1071-0 | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor | | |
10710-2 | Plasmodium sp identified in Blood by Thin film | | |
10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence | | |
10712-8 | Pneumocystis sp identified in Lung tissue | | |
10713-6 | Prototheca identified in Specimen by Culture | | |
10714-4 | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy | | |
10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy | | |
10716-9 | Schistosoma sp identified in Specimen by Organism specific culture | | |
10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination | | |
10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay | | |
10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot | | |
1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells | | |
10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) | | |
10722-7 | Torovirus [Identifier] in Stool by Electron microscopy | | |
10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay | | |
10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay | | |
10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification | | |
10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain | | |
10727-6 | Toxoplasma gondii identified in Tissue | | |
10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture | | |
10729-2 | Trypanosoma sp identified in Blood by Light microscopy | | |
1073-6 | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | | |
10730-0 | Trypanosoma sp identified in Blood by Organism specific culture | | |
10731-8 | Trypanosoma sp identified in Blood by Thick film | | |
10732-6 | Trypanosoma sp identified in Blood by Thin film | | |
10733-4 | Trypanosoma sp identified in Blood by Wet preparation | | |
10734-2 | Varicella zoster virus identified in Skin by Electron microscopy | | |
10735-9 | Viral sequencing [Identifier] in Serum by Sequencing | | |
10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy | | |
10737-5 | Virus identified in Stool by Electron microscopy | | |
10738-3 | Virus identified in Tissue by Electron microscopy | | |
10739-1 | Virus identified in Specimen by Electron microscopy | | |
1074-4 | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor | | |
10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain | | |
10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain | | |
10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified | | |
10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain | | |
10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain | | |
10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain | | |
10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain | | |
10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain | | |
10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain | | |
10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain | | |
1075-1 | Jk sup(b) Ab [Presence] in Serum or Plasma | | |
10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson | | |
10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain | | |
10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain | | |
10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain | | |
10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain | | |
10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott | | |
10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain | | |
10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald | | |
10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain | | |
10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain | | |
1076-9 | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | | |
10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain | | |
10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain | | |
10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain | | |
10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain | | |
10764-9 | Microscopic observation [Identifier] in Sputum by Silver stain | | |
10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain | | |
10766-4 | Microscopic observation [Identifier] in Tissue by Alcian blue stain | | |
10767-2 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated | | |
10768-0 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff | | |
10769-8 | Microscopic observation [Identifier] in Tissue by Alizarin red S stain | | |
1077-7 | Jk sup(b) Ag [Presence] on Red Blood Cells from Donor | | |
10770-6 | Microscopic observation [Identifier] in Tissue by Argentaffin stain | | |
10771-4 | Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain | | |
10772-2 | Microscopic observation [Identifier] in Tissue by Azure-eosin stain | | |
10773-0 | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain | | |
10774-8 | Microscopic observation [Identifier] in Tissue by Bielschowsky stain | | |
10775-5 | Microscopic observation [Identifier] in Tissue by Bleach stain | | |
10776-3 | Microscopic observation [Identifier] in Tissue by Bodian stain | | |
10777-1 | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain | | |
10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain | | |
10779-7 | Microscopic observation [Identifier] in Tissue by Carmine stain.Best | | |
1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells | | |
10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain | | |
10781-3 | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain | | |
10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain | | |
10783-9 | Microscopic observation [Identifier] in Tissue by Crystal violet stain | | |
10784-7 | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific | | |
10785-4 | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain | | |
10786-2 | Deprecated Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron | | |
10787-0 | Microscopic observation [Identifier] in Tissue by Gridley stain | | |
10788-8 | Microscopic observation [Identifier] in Tissue by Hansel stain | | |
10789-6 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain | | |
1079-3 | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | | |
10790-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain | | |
10791-2 | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain | | |
10792-0 | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones | | |
10793-8 | Microscopic observation [Identifier] in Tissue by Methyl green stain | | |
10794-6 | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain | | |
10795-3 | Microscopic observation [Identifier] in Tissue by Methyl violet stain | | |
10796-1 | Microscopic observation [Identifier] in Tissue by Mucicarmine stain | | |
10797-9 | Microscopic observation [Identifier] in Tissue by Neutral red stain | | |
10798-7 | Microscopic observation [Identifier] in Tissue by Oil red O stain | | |
10799-5 | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat | | |
108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) | | |
1080-1 | Js sup(a) Ab [Presence] in Serum or Plasma from Donor | | |
10800-1 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion | | |
10801-9 | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain | | |
10802-7 | Microscopic observation [Identifier] in Tissue by Prussian blue stain | | |
10803-5 | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain | | |
10804-3 | Microscopic observation [Identifier] in Tissue by Reticulin stain | | |
10805-0 | Microscopic observation [Identifier] in Tissue by Safranin stain | | |
10806-8 | Microscopic observation [Identifier] in Tissue by Schmorl stain | | |
10807-6 | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain | | |
10808-4 | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle | | |
10809-2 | Microscopic observation [Identifier] in Tissue by Silver nitrate stain | | |
1081-9 | Js sup(a) Ab [Presence] in Serum or Plasma | | |
10810-0 | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson | | |
10811-8 | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius | | |
10812-6 | Microscopic observation [Identifier] in Tissue by Steiner stain | | |
10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain | | |
10814-2 | Microscopic observation [Identifier] in Tissue by Supravital stain | | |
10815-9 | Microscopic observation [Identifier] in Tissue by Tetrachrome stain | | |
10816-7 | Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain | | |
10817-5 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley | | |
10818-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified | | |
10819-1 | Microscopic observation [Identifier] in Tissue by Wade stain | | |
1082-7 | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | | |
10820-9 | Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain | | |
10821-7 | Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain | | |
10822-5 | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer | | |
10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale | | |
10824-1 | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain | | |
10825-8 | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain | | |
10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain | | |
10827-4 | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain | | |
10828-2 | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain | | |
10829-0 | Silicon [Mass/volume] in Serum or Plasma | | |
10000-8 | | R wave duration in lead AVR | |
10001-6 | | R wave duration in lead I | |
100018-1 | | Hospice care Note | |
10002-4 | | R wave duration in lead II | |
10003-2 | | R wave duration in lead III | |
100034-8 | | Provider of automated external defibrillator use | |
100035-5 | | Exam finding location of Chest | |
100036-3 | | Exam finding location of Lung | |
100037-1 | | Patient contact disposition EMS unit | |
100038-9 | | Patient evaluation disposition EMS unit | |
100039-7 | | Crew disposition for patient care EMS unit | |
10004-0 | | R wave duration in lead V1 | |
100040-5 | | Patient transport disposition EMS unit | |
10005-7 | | R wave duration in lead V2 | |
10006-5 | | R wave duration in lead V3 | |
100062-9 | | Standard Dermatology Outcome Measures panel | |
100063-7 | | Primary skin concern | |
100064-5 | | Itch severity Reporting Period - Reported | |
100065-2 | | Satisfied with treatment | |
100066-0 | | Specular microscopy panel | |
100067-8 | | Eye Image magnification | |
100068-6 | | Right eye Fixation point [Angle] | |
100069-4 | | Left eye Fixation point [Angle] | |
10007-3 | | R wave duration in lead V4 | |
100070-2 | | Right cornea Cell density | |
100071-0 | | Left cornea Cell density | |
100072-8 | | Right cornea Coefficient of variation | |
100073-6 | | Left cornea Coefficient of variation | |
100074-4 | | Right cornea Hexagonality | |
100075-1 | | Left cornea Hexagonality | |
100076-9 | | Right cornea Endothelial cells counted | |
100077-7 | | Left cornea Endothelial cells counted | |
100078-5 | | Right cornea Endothelial cell area.min | |
100079-3 | | Left cornea Endothelial cell area.min | |
10008-1 | | R wave duration in lead V5 | |
100080-1 | | Right cornea Endothelial cell area.max | |
100081-9 | | Left cornea Endothelial cell area.max | |
100082-7 | | Right cornea Endothelial cell area.mean | |
100083-5 | | Left cornea Endothelial cell area.mean | |
100084-3 | | Right cornea Cell area.standard deviation | |
100085-0 | | Left cornea Cell area.standard deviation | |
100086-8 | | Right cornea Type of Analysis method by Specular microscopy | |
10009-9 | | R wave duration in lead V6 | |
10010-7 | | R' wave amplitude in lead AVF | |
10011-5 | | R' wave amplitude in lead AVL | |
10012-3 | | R' wave amplitude in lead AVR | |
10013-1 | | R' wave amplitude in lead I | |
10014-9 | | R' wave amplitude in lead II | |
10015-6 | | R' wave amplitude in lead III | |
100155-1 | | Left cornea Type of Analysis method by Specular microscopy | |
10016-4 | | R' wave amplitude in lead V1 | |
100160-1 | | Knee replacement | |
100161-9 | | Charnley Functional Classification | |
100162-7 | | Knee alignment W standing X-ray measured | |
100163-5 | | Knee medial AndOr lateral instability W full extension | |
100164-3 | | Knee AP instability W 90 degree flexion | |
100165-0 | | Knee range of motion | |
100166-8 | | Flexion contracture range of Knee | |
100167-6 | | Extensor lag range of Knee | |
10017-2 | | R' wave amplitude in lead V2 | |
10018-0 | | R' wave amplitude in lead V3 | |
10019-8 | | R' wave amplitude in lead V4 | |
10020-6 | | R' wave amplitude in lead V5 | |
10021-4 | | R' wave amplitude in lead V6 | |
100214-6 | | Dental model prior authorization Document | |
100215-3 | | Episode of care medical records Document Transplant surgery | |
100216-1 | | Surgical synoptic report | |
100217-9 | | Surgical oncology synoptic report | |
100218-7 | | Surgical oncology of colon synoptic report | |
100219-5 | | Surgical oncology of melanoma synoptic report | |
10022-2 | | R' wave duration in lead AVF | |
100220-3 | | Surgical oncology of breast synoptic report | |
100221-1 | | Surgical oncology of thyroid synoptic report | |
100222-9 | | Surgical oncology of pancreas synoptic report | |
100223-7 | | Physical findings of Retina Narrative | |
100224-5 | | Cardiac left ventricular segmental wall motion by echo panel | |
100225-2 | | Bone density quantitative ultrasound study | |
100226-0 | | Small bowel capsule endoscopy study Document | |
100227-8 | | Colon capsule endoscopy study Document | |
100228-6 | | Upper gastrointestinal capsule endoscopy study Document | |
100229-4 | | Endoscopic ultrasound study Document | |
10023-0 | | R' wave duration in lead AVL | |
100230-2 | | Routine prenatal assessment panel | |
100231-0 | | Endobronchial ultrasound study | |
10024-8 | | R' wave duration in lead AVR | |
10025-5 | | R' wave duration in lead I | |
100256-7 | | Fallen in last 6 months | |
100257-5 | | Feel unsteady when standing or walking | |
100258-3 | | History of fall related injury | |
10026-3 | | R' wave duration in lead II | |
10027-1 | | R' wave duration in lead III | |
10028-9 | | R' wave duration in lead V1 | |
100282-3 | | Vaccine exemption certificate | |
10029-7 | | R' wave duration in lead V2 | |
100298-9 | | Repetition count | |
10030-5 | | R' wave duration in lead V3 | |
100300-3 | | End time Unspecified body region | |
100301-1 | | Start time Unspecified body region | |
100302-9 | | Time period start and end panel Unspecified body region | |
100303-7 | | Condition certainty of presence | |
100304-5 | | Flights climbed [#] Reporting Period | |
10031-3 | | R' wave duration in lead V4 | |
10032-1 | | R' wave duration in lead V5 | |
10033-9 | | R' wave duration in lead V6 | |
10034-7 | | S wave amplitude in lead AVF | |
100348-2 | | Model for end-stage liver disease sodium score | |
100349-0 | | US.doppler Penis vessels W vasodilator IV | |
10035-4 | | S wave amplitude in lead AVL | |
10036-2 | | S wave amplitude in lead AVR | |
100369-8 | | NM Thyroid gland Views W Tl-201 IV | |
10037-0 | | S wave amplitude in lead I | |
10038-8 | | S wave amplitude in lead II | |
100382-1 | | FDA package insert REMS addressed risk | |
10039-6 | | S wave amplitude in lead III | |
10040-4 | | S wave amplitude in lead V1 | |
10041-2 | | S wave amplitude in lead V2 | |
10042-0 | | S wave amplitude in lead V3 | |
10043-8 | | S wave amplitude in lead V4 | |
100438-1 | | Adolescent medicine Outpatient Progress note | |
100439-9 | | Allergy and Immunology Outpatient Progress note | |
10044-6 | | S wave amplitude in lead V5 | |
100440-7 | | Allergy Outpatient Progress note | |
100441-5 | | Attending Outpatient Progress note | |
100442-3 | | Audiology Outpatient Progress note | |
100443-1 | | Bariatric surgery Outpatient Progress note | |
100444-9 | | Blood banking and transfusion medicine Outpatient Progress note | |
100445-6 | | Bone Marrow Transplant Outpatient Progress note | |
100446-4 | | Breastfeeding Outpatient Progress note | |
100447-2 | | Burn management Outpatient Progress note | |
100448-0 | | Cardiac surgery Outpatient Progress note | |
100449-8 | | Cardiopulmonary Outpatient Progress note | |
10045-3 | | S wave amplitude in lead V6 | |
100450-6 | | Child and adolescent psychiatry Outpatient Progress note | |
100451-4 | | Chiropractic medicine Outpatient Progress note | |
100452-2 | | Clinical cardiac electrophysiology Outpatient Progress note | |
100453-0 | | Clinical genetics Outpatient Progress note | |
100454-8 | | Clinical neurophysiology Outpatient Progress note | |
100455-5 | | Clinical pathology Outpatient Progress note | |
100456-3 | | Colon and rectal surgery Outpatient Progress note | |
100457-1 | | Consultant Outpatient Progress note | |
100458-9 | | Outpatient COVID-19 Intubation Progress note | |
100459-7 | | Outpatient COVID-19 Progress note | |
10046-1 | | S wave duration in lead AVF | |
100460-5 | | Dermatology Outpatient Progress note | |
100461-3 | | Developmental-behavioral pediatrics Outpatient Progress note | |
100462-1 | | Dialysis and Therapeutic apheresis Outpatient Progress note | |
100463-9 | | Eating disorders Outpatient Progress note | |
100464-7 | | Endocrinology Outpatient Progress note | |
100465-4 | | Family medicine Outpatient Progress note | |
100466-2 | | Gastroenterology Outpatient Progress note | |
100467-0 | | Geriatric medicine Outpatient Progress note | |
100468-8 | | Gynecologic oncology Outpatient Progress note | |
100469-6 | | Gynecology Outpatient Progress note | |
10047-9 | | S wave duration in lead AVL | |
100470-4 | | Healthcare navigator Outpatient Progress note | |
100471-2 | | Heart failure Outpatient Progress note | |
100472-0 | | Heart failure+Transplant cardiology Outpatient Progress note | |
100473-8 | | Hematology Outpatient Progress note | |
100474-6 | | Hematology+Medical oncology Outpatient Progress note | |
100475-3 | | Hepatology Outpatient Progress note | |
100476-1 | | Immunology Outpatient Progress note | |
100477-9 | | Infectious disease Outpatient Progress note | |
100478-7 | | Internal medicine Outpatient Progress note | |
100479-5 | | Interventional cardiology Outpatient Progress note | |
10048-7 | | S wave duration in lead AVR | |
100480-3 | | Interventional radiology Outpatient Progress note | |
100481-1 | | Outpatient Mechanical circulatory support Progress note | |
100482-9 | | Medical Aid in Dying Outpatient Progress note | |
100483-7 | | Mental health Outpatient Progress note | |
100484-5 | | Multi-specialty program Outpatient Progress note | |
100485-2 | | Neonatal perinatal medicine Outpatient Progress note | |
100486-0 | | Nephrology Outpatient Progress note | |
100487-8 | | Neurological surgery Outpatient Progress note | |
100488-6 | | Neurology Outpatient Progress note | |
100489-4 | | Neurology with special qualifications in child neurology Outpatient Progress note | |
10049-5 | | S wave duration in lead I | |
100490-2 | | Nurse practitioner Outpatient Progress note | |
100491-0 | | Nurse Outpatient Progress note | |
100492-8 | | Nutrition and dietetics Outpatient Progress note | |
100493-6 | | Obstetrics and Gynecology Outpatient Progress note | |
100494-4 | | Obstetrics Outpatient Progress note | |
100495-1 | | Occupational therapy Outpatient Progress note | |
100496-9 | | Oncology Outpatient Progress note | |
100497-7 | | Ophthalmology Outpatient Progress note | |
100498-5 | | Optometry Outpatient Progress note | |
100499-3 | | Oral and Maxillofacial Surgery Outpatient Progress note | |
10050-3 | | S wave duration in lead II | |
100500-8 | | Orthopaedic surgery Outpatient Progress note | |
100501-6 | | Orthotics prosthetics Outpatient Progress note | |
100502-4 | | Otolaryngology Outpatient Progress note | |
100503-2 | | Pain medicine Outpatient Progress note | |
100504-0 | | Palliative care Outpatient Progress note | |
100505-7 | | Pediatric cardiology Outpatient Progress note | |
100506-5 | | Pediatric dermatology Outpatient Progress note | |
100507-3 | | Pediatric endocrinology Outpatient Progress note | |
100508-1 | | Pediatric gastroenterology Outpatient Progress note | |
100509-9 | | Pediatric hematology-oncology Outpatient Progress note | |
10051-1 | | S wave duration in lead III | |
100510-7 | | Pediatric infectious diseases Outpatient Progress note | |
100511-5 | | Pediatric otolaryngology Outpatient Progress note | |
100512-3 | | Pediatric pulmonology Outpatient Progress note | |
100513-1 | | Pediatric rheumatology Outpatient Progress note | |
100514-9 | | Pediatric surgery Outpatient Progress note | |
100515-6 | | Pediatric transplant hepatology Outpatient Progress note | |
100516-4 | | Pediatric urology Outpatient Progress note | |
100517-2 | | Pharmacogenomics Outpatient Progress note | |
100518-0 | | Physical medicine and rehab Outpatient Progress note | |
100519-8 | | Physical therapy Outpatient Progress note | |
10052-9 | | S wave duration in lead V1 | |
100520-6 | | Plastic surgery Outpatient Progress note | |
100521-4 | | Podiatry Outpatient Progress note | |
100522-2 | | Psychiatry Hospital Progress note | |
100523-0 | | Psychology Outpatient Progress note | |
100524-8 | | Pulmonary Outpatient Progress note | |
100525-5 | | Radiation oncology Outpatient Progress note | |
100526-3 | | Radiology Outpatient Progress note | |
100527-1 | | Recreational therapy Outpatient Progress note | |
100528-9 | | Reproductive endocrinology and infertility Outpatient Progress note | |
100529-7 | | Research Outpatient Progress note | |
10053-7 | | S wave duration in lead V2 | |
100530-5 | | Rheumatology Outpatient Progress note | |
100531-3 | | Sleep medicine Outpatient Progress note | |
100532-1 | | Social worker Outpatient Progress note | |
100533-9 | | Solid Organ Transplant Outpatient Progress note | |
100534-7 | | Speech-language pathology Outpatient Progress note | |
100535-4 | | Spinal surgery Outpatient Progress note | |
100536-2 | | Sports medicine Outpatient Progress note | |
100537-0 | | Surgery of the hand Outpatient Progress note | |
100538-8 | | Telehealth+Outpatient Progress note | |
100539-6 | | Thromboembolism Outpatient Progress note | |
10054-5 | | S wave duration in lead V3 | |
100540-4 | | Transplant surgery Outpatient Progress note | |
100541-2 | | Trauma Outpatient Progress note | |
100542-0 | | Urology Outpatient Progress note | |
100543-8 | | Vascular neurology Outpatient Progress note | |
100544-6 | | Vascular surgery Outpatient Progress note | |
100545-3 | | Wound care management Outpatient Progress note | |
100546-1 | | Wound, Ostomy, and Continence Care Outpatient Progress note | |
100547-9 | | Adolescent medicine Hospital Progress note | |
100548-7 | | Allergy and Immunology Hospital Progress note | |
100549-5 | | Allergy Hospital Progress note | |
10055-2 | | S wave duration in lead V4 | |
100550-3 | | Attending Hospital Progress note | |
100551-1 | | Audiology Hospital Progress note | |
100552-9 | | Bariatric surgery Hospital Progress note | |
100553-7 | | Blood banking and transfusion medicine Hospital Progress note | |
100554-5 | | Bone Marrow Transplant Hospital Progress note | |
100555-2 | | Breastfeeding Hospital Progress note | |
100556-0 | | Burn management Hospital Progress note | |
100557-8 | | Cardiac surgery Hospital Progress note | |
100558-6 | | Cardiopulmonary Hospital Progress note | |
100559-4 | | Child and adolescent psychiatry Hospital Progress note | |
10056-0 | | S wave duration in lead V5 | |
100560-2 | | Clinical cardiac electrophysiology Hospital Progress note | |
100561-0 | | Clinical genetics Hospital Progress note | |
100562-8 | | Clinical neurophysiology Hospital Progress note | |
100563-6 | | Clinical pathology Hospital Progress note | |
100564-4 | | Colon and rectal surgery Hospital Progress note | |
100565-1 | | Consultant Hospital Progress note | |
100566-9 | | Dentistry Hospital Progress note | |
100567-7 | | Dermatology Hospital Progress note | |
100568-5 | | Developmental-behavioral pediatrics Hospital Progress note | |
100569-3 | | Dialysis and Therapeutic apheresis Hospital Progress note | |
10057-8 | | S wave duration in lead V6 | |
100570-1 | | Eating disorders Hospital Progress note | |
100571-9 | | Endocrinology Hospital Progress note | |
100572-7 | | Family medicine Hospital Progress note | |
100573-5 | | Gastroenterology Hospital Progress note | |
100574-3 | | General medicine Hospital Progress note | |
100575-0 | | Geriatric medicine Hospital Progress note | |
100576-8 | | Gynecologic oncology Hospital Progress note | |
100577-6 | | Gynecology Hospital Progress note | |
100578-4 | | Healthcare navigator Hospital Progress note | |
100579-2 | | Heart failure Hospital Progress note | |
10058-6 | | S' wave amplitude in lead AVF | |
100580-0 | | Heart failure+Transplant cardiology Hospital Progress note | |
100581-8 | | Hematology Hospital Progress note | |
100582-6 | | Hematology+Medical oncology Hospital Progress note | |
100583-4 | | Hepatology Hospital Progress note | |
100584-2 | | Immunology Hospital Progress note | |
100585-9 | | Infectious disease Hospital Progress note | |
100586-7 | | Internal medicine Hospital Progress note | |
100587-5 | | Interventional cardiology Hospital Progress note | |
100588-3 | | Interventional radiology Hospital Progress note | |
100589-1 | | Hospital Mechanical circulatory support Progress note | |
10059-4 | | S' wave amplitude in lead AVL | |
100590-9 | | Medical Aid in Dying Hospital Progress note | |
100591-7 | | Mental health Hospital Progress note | |
100592-5 | | Multi-specialty program Hospital Progress note | |
100593-3 | | Neonatal perinatal medicine Hospital Progress note | |
100594-1 | | Nephrology Hospital Progress note | |
100595-8 | | Neurological surgery Hospital Progress note | |
100596-6 | | Neurology Hospital Progress note | |
100597-4 | | Neurology with special qualifications in child neurology Hospital Progress note | |
100598-2 | | Nurse practitioner Hospital Progress note | |
100599-0 | | Nurse Hospital Progress note | |
10060-2 | | S' wave amplitude in lead AVR | |
100600-6 | | Nutrition and dietetics Hospital Progress note | |
100601-4 | | Obstetrics and Gynecology Hospital Progress note | |
100602-2 | | Obstetrics Hospital Progress note | |
100603-0 | | Occupational therapy Hospital Progress note | |
100604-8 | | Oncology Hospital Progress note | |
100605-5 | | Ophthalmology Hospital Progress note | |
100606-3 | | Oral and Maxillofacial Surgery Hospital Progress note | |
100607-1 | | Orthopaedic surgery Hospital Progress note | |
100608-9 | | Orthotics prosthetics Hospital Progress note | |
100609-7 | | Otolaryngology Hospital Progress note | |
10061-0 | | S' wave amplitude in lead I | |
100610-5 | | Pain medicine Hospital Progress note | |
100611-3 | | Palliative care Hospital Progress note | |
100612-1 | | Pastoral care Hospital Progress note | |
100613-9 | | Pediatric cardiology Hospital Progress note | |
100614-7 | | Pediatric dermatology Hospital Progress note | |
100615-4 | | Pediatric endocrinology Hospital Progress note | |
100616-2 | | Pediatric gastroenterology Hospital Progress note | |
100617-0 | | Pediatric hematology-oncology Hospital Progress note | |
100618-8 | | Pediatric infectious diseases Hospital Progress note | |
100619-6 | | Pediatric otolaryngology Hospital Progress note | |
10062-8 | | S' wave amplitude in lead II | |
100620-4 | | Pediatric pulmonology Hospital Progress note | |
100621-2 | | Pediatric rheumatology Hospital Progress note | |
100622-0 | | Pediatric surgery Hospital Progress note | |
100623-8 | | Pediatric transplant hepatology Hospital Progress note | |
100624-6 | | Pharmacogenomics Hospital Progress note | |
100625-3 | | Pharmacology Hospital Progress note | |
100626-1 | | Physical medicine and rehab Hospital Progress note | |
100627-9 | | Physical therapy Hospital Progress note | |
100628-7 | | Plastic surgery Hospital Progress note | |
100629-5 | | Podiatry Hospital Progress note | |
10063-6 | | S' wave amplitude in lead III | |
100630-3 | | Psychology Hospital Progress note | |
100631-1 | | Radiation oncology Hospital Progress note | |
100632-9 | | Radiology Hospital Progress note | |
100633-7 | | Rapid response team Hospital Progress note | |
100634-5 | | Recreational therapy Hospital Progress note | |
100635-2 | | Reproductive endocrinology and infertility Hospital Progress note | |
100636-0 | | Research Hospital Progress note | |
100637-8 | | Rheumatology Hospital Progress note | |
100638-6 | | Sleep medicine Hospital Progress note | |
100639-4 | | Social worker Hospital Progress note | |
10064-4 | | S' wave amplitude in lead V1 | |
100640-2 | | Solid Organ Transplant Hospital Progress note | |
100641-0 | | Speech-language pathology Hospital Progress note | |
100642-8 | | Spinal surgery Hospital Progress note | |
100643-6 | | Surgery of the hand Hospital Progress note | |
100644-4 | | Thromboembolism Hospital Progress note | |
100645-1 | | Trauma Hospital Progress note | |
100646-9 | | Urology Hospital Progress note | |
100647-7 | | Vascular neurology Hospital Progress note | |
100648-5 | | Vascular surgery Hospital Progress note | |
100649-3 | | Wound care management Hospital Progress note | |
10065-1 | | S' wave amplitude in lead V2 | |
100650-1 | | Wound, Ostomy, and Continence Care Hospital Progress note | |
100651-9 | | Hospital COVID-19 Intubation Progress note | |
100652-7 | | Pure tone bone conduction threshold audiometry panel | |
100653-5 | | Pure tone air conduction threshold audiometry panel | |
100655-0 | | XR Sella turcica Lateral | |
100656-8 | | Maternal and fetal medicine Outpatient Progress note | |
100657-6 | | Maternal and fetal medicine Telephone encounter+Hospital Progress note | |
100658-4 | | Hospital COVID-19 Progress note | |
100659-2 | | Maternal and fetal medicine Hospital Progress note | |
10066-9 | | S' wave amplitude in lead V3 | |
100660-0 | | Maternal and fetal medicine Telephone encounter+Outpatient Progress note | |
100661-8 | | Psychiatry Outpatient Progress note | |
10067-7 | | S' wave amplitude in lead V4 | |
10068-5 | | S' wave amplitude in lead V5 | |
10069-3 | | S' wave amplitude in lead V6 | |
100697-2 | | Interventional radiology Outpatient Note | |
100698-0 | | Social Determinants of Health screening report Document | |
10070-1 | | S' wave duration in lead AVF | |
10071-9 | | S' wave duration in lead AVL | |
100718-6 | | Undersea and hyperbaric medicine Discharge summary | |
100719-4 | | Surgical oncology Discharge summary | |
10072-7 | | S' wave duration in lead AVR | |
100720-2 | | Reproductive endocrinology and infertility Discharge summary | |
100721-0 | | Community health care Discharge summary | |
100722-8 | | Integrative medicine Discharge summary | |
100723-6 | | Sports medicine Discharge summary | |
100724-4 | | Diabetology Discharge summary | |
100725-1 | | Optometry Discharge summary | |
100726-9 | | Podiatry Discharge summary | |
100727-7 | | Chiropractic medicine Discharge summary | |
100728-5 | | Cardiac surgery Discharge summary | |
100729-3 | | Breastfeeding Discharge summary | |
10073-5 | | S' wave duration in lead I | |
100730-1 | | Transplant surgery Discharge summary | |
100731-9 | | Urgent care center Discharge summary | |
10074-3 | | S' wave duration in lead II | |
10075-0 | | S' wave duration in lead III | |
100752-5 | | Exacerbating factors - Reported | |
100753-3 | | Alleviating factors - Reported | |
100758-2 | | Estimated lung age by based on clinical data | |
100759-0 | | Inspiratory reserve [Volume] Respiratory system by Spirometry | |
10076-8 | | S' wave duration in lead V1 | |
100760-8 | | XR Radius and Ulna - left Single view | |
10077-6 | | S' wave duration in lead V2 | |
10078-4 | | S' wave duration in lead V3 | |
10079-2 | | S' wave duration in lead V4 | |
10080-0 | | S' wave duration in lead V5 | |
10081-8 | | S' wave duration in lead V6 | |
10082-6 | | ST initial amplitude 6 ms in lead AVF | |
100821-8 | | National POLST form: portable medical order panel | |
100822-6 | | Cardiopulmonary resuscitation orders | |
100823-4 | | Initial portable medical treatment orders | |
100824-2 | | Additional portable medical orders or instructions | |
100825-9 | | Medically assisted nutrition orders | |
100826-7 | | Portable medical order AndOr advance directive review | |
100827-5 | | Portable medical order discussion participants | |
100828-3 | | Portable medical order administrative information | |
10083-4 | | ST initial amplitude 6 ms in lead AVL | |
10084-2 | | ST initial amplitude 6 ms in lead AVR | |
10085-9 | | ST initial amplitude 6 ms in lead I | |
100852-3 | | NM Bones Views for metastasis W Sr-89 IV | |
100853-1 | | NM Pericardial space Pericardial effusion | |
10086-7 | | ST initial amplitude 6 ms in lead II | |
10087-5 | | ST initial amplitude 6 ms in lead III | |
100875-4 | | Fetal Heart Document limited US | |
100876-2 | | Fetal Heart Document US | |
100877-0 | | US Heart Transesophageal during surgery | |
100878-8 | | Endoscopic ultrasound study Upper GI tract Document | |
100879-6 | | US Guidance for cryoablation of Breast - right | |
10088-3 | | ST initial amplitude 6 ms in lead V1 | |
100880-4 | | US Guidance for cryoablation of Breast - left | |
100881-2 | | MR Guidance for cryoablation of Bone | |
100882-0 | | MR Peritoneum W contrast percutaneous intraperitoneal | |
100883-8 | | MR Guidance for biopsy of Kidney - left | |
100884-6 | | MR Guidance for biopsy of Kidney - right | |
10089-1 | | ST initial amplitude 6 ms in lead V2 | |
100894-5 | | Recommended screening frequency Narrative | |
10090-9 | | ST initial amplitude 6 ms in lead V3 | |
10091-7 | | ST initial amplitude 6 ms in lead V4 | |
10092-5 | | ST initial amplitude 6 ms in lead V5 | |
10093-3 | | ST initial amplitude 6 ms in lead V6 | |
10094-1 | | ST slope in lead AVF | |
10095-8 | | ST slope in lead AVL | |
10096-6 | | ST slope in lead AVR | |
100966-1 | | Oncofertility consultation note | |
100967-9 | | Fetal Document Fetal Heart Tracing | |
10097-4 | | ST slope in lead I | |
10098-2 | | ST slope in lead II | |
10099-0 | | ST slope in lead III | |
10100-6 | | ST slope in lead V1 | |
10101-4 | | ST slope in lead V2 | |
10102-2 | | ST slope in lead V3 | |
10103-0 | | ST slope in lead V4 | |
10104-8 | | ST slope in lead V5 | |
10105-5 | | ST slope in lead V6 | |
10106-3 | | ST wave end displacement in lead AVF | |
10107-1 | | ST wave end displacement in lead AVL | |
10108-9 | | ST wave end displacement in lead AVR | |
10109-7 | | ST wave end displacement in lead I | |
10110-5 | | ST wave end displacement in lead II | |
10111-3 | | ST wave end displacement in lead III | |
10112-1 | | ST wave end displacement in lead V1 | |
10113-9 | | ST wave end displacement in lead V2 | |
10114-7 | | ST wave end displacement in lead V3 | |
10115-4 | | ST wave end displacement in lead V4 | |
10116-2 | | ST wave end displacement in lead V5 | |
10117-0 | | ST wave end displacement in lead V6 | |
10118-8 | | ST wave mid displacement in lead AVF | |
10119-6 | | ST wave mid displacement in lead AVL | |
10120-4 | | ST wave mid displacement in lead AVR | |
10121-2 | | ST wave mid displacement in lead I | |
10122-0 | | ST wave mid displacement in lead II | |
10123-8 | | ST wave mid displacement in lead III | |
10124-6 | | ST wave mid displacement in lead V1 | |
10125-3 | | ST wave mid displacement in lead V2 | |
10126-1 | | ST wave mid displacement in lead V3 | |
10127-9 | | ST wave mid displacement in lead V4 | |
10128-7 | | ST wave mid displacement in lead V5 | |
10129-5 | | ST wave mid displacement in lead V6 | |
10130-3 | | T' wave amplitude in lead AVF | |
10131-1 | | T' wave amplitude in lead AVL | |
10132-9 | | T' wave amplitude in lead AVR | |
10133-7 | | T' wave amplitude in lead I | |
10134-5 | | T' wave amplitude in lead II | |
10135-2 | | T' wave amplitude in lead III | |
10136-0 | | T' wave amplitude in lead V1 | |
10137-8 | | T' wave amplitude in lead V2 | |
10138-6 | | T' wave amplitude in lead V3 | |
10139-4 | | T' wave amplitude in lead V4 | |
10140-2 | | T' wave amplitude in lead V5 | |
10141-0 | | T' wave amplitude in lead V6 | |
10142-8 | | T wave amplitude in lead AVF | |
10143-6 | | T wave amplitude in lead AVL | |
10144-4 | | T wave amplitude in lead AVR | |
10145-1 | | T wave amplitude in lead I | |
10146-9 | | T wave amplitude in lead II | |
10147-7 | | T wave amplitude in lead III | |
10148-5 | | T wave amplitude in lead V1 | |
10149-3 | | T wave amplitude in lead V2 | |
10150-1 | | T wave amplitude in lead V3 | |
10151-9 | | T wave amplitude in lead V4 | |
10152-7 | | T wave amplitude in lead V5 | |
10153-5 | | T wave amplitude in lead V6 | |
10154-3 | | Chief complaint Narrative - Reported | |
10155-0 | | History of allergies, reported | |
10156-8 | | History of Childhood diseases Narrative | |
10157-6 | | History of family member diseases Narrative | |
10158-4 | | History of Functional status Narrative | |
10159-2 | | History of Industrial exposure Narrative | |
10160-0 | | History of Medication use Narrative | |
10161-8 | | History of Occupational exposure Narrative | |
10162-6 | | History of pregnancies Narrative | |
10163-4 | | History of pregnancies | |
10164-2 | | History of Present illness Narrative | |
10165-9 | | Deprecated History of psychiatric symptoms and diseases Narrative | |
10166-7 | | History of Social function Narrative | |
10167-5 | | History of Surgical procedures Narrative | |
10168-3 | | History of Cardiovascular system disorders Narrative | |
10169-1 | | History of Ear disorders Narrative | |
10170-9 | | History of Endocrine system disorders Narrative | |
10171-7 | | History of Eyes disorders Narrative | |
10172-5 | | History of Hematologic system disorders Narrative | |
10173-3 | | History of Musculoskeletal system disorders Narrative | |
10174-1 | | History of Nose disorders Narrative | |
10175-8 | | History of Oral cavity disorders Narrative | |
10176-6 | | History of Reproductive system disorders Narrative | |
10177-4 | | History of Respiratory system disorders Narrative | |
10178-2 | | History of Skin disorders Narrative | |
10179-0 | | History of Throat and Neck disorders Narrative | |
10180-8 | | History of Throat and Neck disorders | |
10181-6 | | History of Urinary tract disorders Narrative | |
10182-4 | | History of Travel Narrative | |
10183-2 | | Hospital discharge medications Narrative | |
10184-0 | | Hospital discharge physical findings Narrative | |
10185-7 | | Hospital discharge procedures Narrative | |
10186-5 | | Identifying information Narrative Observed | |
10187-3 | | Review of systems Narrative - Reported | |
10188-1 | | Review of systems overview Narrative - Reported | |
10189-9 | | Review of systems overview - Reported | |
10190-7 | | Mental status Narrative | |
10191-5 | | Physical findings of Abdomen Narrative | |
10192-3 | | Physical findings of Back Narrative | |
10193-1 | | Physical findings of Breasts Narrative | |
10194-9 | | Physical findings of Neurologic deep tendon reflexes Narrative | |
10195-6 | | Physical findings of Ear Narrative | |
10196-4 | | Physical findings of Extremities Narrative | |
10197-2 | | Physical findings of Eye Narrative | |
10198-0 | | Physical findings of Genitourinary tract Narrative | |
10199-8 | | Physical findings of Head Narrative | |
10200-4 | | Physical findings of Heart Narrative | |
10201-2 | | Physical findings of Mouth and Throat and Teeth Narrative | |
10202-0 | | Physical findings of Nervous system Narrative | |
10203-8 | | Physical findings of Nose Narrative | |
10204-6 | | Physical findings of Pelvis Narrative | |
10205-3 | | Physical findings of Rectum Narrative | |
10206-1 | | Physical findings of Skin Narrative | |
10207-9 | | Physical findings of Thorax and Lungs Narrative | |
10208-7 | | Physical findings of Vessels Narrative | |
10209-5 | | Physical findings of Neurologic balance and Coordination Narrative | |
10210-3 | | Physical findings of General status Narrative | |
10211-1 | | Physical findings of Sense of touch Narrative | |
10212-9 | | Physical findings of Strength Narrative | |
10213-7 | | Surgical operation note anesthesia Narrative | |
10214-5 | | Surgical operation note anesthesia duration | |
10215-2 | | Surgical operation note findings Narrative | |
10216-0 | | Surgical operation note fluids Narrative | |
10217-8 | | Surgical operation note indications [Interpretation] Narrative | |
10218-6 | | Surgical operation note postoperative diagnosis Narrative | |
10219-4 | | Surgical operation note preoperative diagnosis Narrative | |
10220-2 | | Surgical operation note prep time duration | |
10221-0 | | Surgical operation note specimens taken Narrative | |
10222-8 | | Surgical operation note surgical complications [Interpretation] Narrative | |
10223-6 | | Surgical operation note surgical procedure Narrative | |
10224-4 | | Hemodynamic method special circumstances | |
10225-1 | | Cardiac measurement device Institution inventory number | |
10227-7 | | Cardiac measurement device Vendor model number | |
10228-5 | | Cardiac measurement device Vendor serial number | |
10229-3 | | Hemodynamic method Type of | |
10230-1 | | Left ventricular Ejection fraction | |
10231-9 | | Right ventricular Ejection fraction | |
10249-1 | | Heart rate device Institution inventory number | |
10250-9 | | Heart rate device Vendor model number | |
10251-7 | | Heart rate device Vendor serial number | |
10252-5 | | Biliary drain site | |
10253-3 | | Type of Biliary drain | |
10254-1 | | Type of Peritoneal drain | |
10255-8 | | Type of Subarachnoid drain | |
10256-6 | | Biliary drain Institution inventory number | |
10257-4 | | Chest tube Institution inventory number | |
10258-2 | | Enteral tube Institution inventory number | |
10259-0 | | Gastrostomy tube Institution inventory number | |
10260-8 | | GI tube Institution inventory number | |
10261-6 | | Intravascular tube Institution inventory number | |
10262-4 | | IO tube Institution inventory number | |
10263-2 | | Nasogastric tube Institution inventory number | |
10264-0 | | Oral tube Institution inventory number | |
10265-7 | | Peritoneal drain Institution inventory number | |
10266-5 | | Peritoneal tube Institution inventory number | |
10267-3 | | Rate control device Institution inventory number | |
10268-1 | | Stool collection device Institution inventory number | |
10269-9 | | Subarachnoid drain Institution inventory number | |
10270-7 | | Synovial drain Institution inventory number | |
10271-5 | | Tube or drain Institution inventory number | |
10272-3 | | Upper GI tube Institution inventory number | |
10273-1 | | Bladder irrigation tube Institution inventory number | |
10274-9 | | Urine tube Institution inventory number | |
10275-6 | | Wound drain device Institution inventory number | |
10276-4 | | Peritoneal drain site | |
10277-2 | | Stool collection site | |
10278-0 | | Subarachnoid drain site | |
10279-8 | | Biliary drain Vendor model number | |
10280-6 | | Chest tube Vendor model number | |
10281-4 | | Enteral tube Vendor model number | |
10282-2 | | Gastrostomy tube Vendor model number | |
10283-0 | | GI tube Vendor model number | |
10284-8 | | Intravascular tube Vendor model number | |
10285-5 | | IO tube Vendor model number | |
10286-3 | | Nasogastric tube Vendor model number | |
10287-1 | | Oral tube Vendor model number | |
10288-9 | | Peritoneal drain Vendor model number | |
10289-7 | | Peritoneal tube Vendor model number | |
10290-5 | | Rate control device Vendor model number | |
10291-3 | | Stool collection device Vendor model number | |
10292-1 | | Subarachnoid drain Vendor model number | |
10293-9 | | Synovial drain Vendor model number | |
10294-7 | | Tube or drain Vendor model number | |
10295-4 | | Upper GI tube Vendor model number | |
10296-2 | | Bladder irrigation tube Vendor model number | |
10297-0 | | Urine tube Vendor model number | |
10298-8 | | Wound drain device Vendor model number | |
10299-6 | | Biliary drain Vendor serial number | |
10300-2 | | Chest tube Vendor serial number | |
10301-0 | | Enteral tube Vendor serial number | |
10302-8 | | Gastrostomy tube Vendor serial number | |
10303-6 | | GI tube Vendor serial number | |
10304-4 | | Intravascular tube Vendor serial number | |
10305-1 | | IO tube Vendor serial number | |
10306-9 | | Nasogastric tube Vendor serial number | |
10307-7 | | Oral tube Vendor serial number | |
10308-5 | | Peritoneal drain Vendor serial number | |
10309-3 | | Peritoneal tube Vendor serial number | |
10310-1 | | Rate control device Vendor serial number | |
10311-9 | | Stool collection device Vendor serial number | |
10312-7 | | Subarachnoid drain Vendor serial number | |
10313-5 | | Synovial drain Vendor serial number | |
10314-3 | | Tube or drain Vendor serial number | |
10315-0 | | Upper GI tube Vendor serial number | |
10316-8 | | Bladder irrigation tube Vendor serial number | |
10317-6 | | Urine tube Vendor serial number | |
10318-4 | | Wound drain device Vendor serial number | |
10319-2 | | Enema device Institution inventory number | |
10320-0 | | Enema device Vendor model number | |
10321-8 | | Enema device Vendor serial number | |
10322-6 | | Potassium intake 24 hour | |
10323-4 | | Wound drain fluid [Appearance] Lower GI tract | |
10324-2 | | Breath rate device Institution inventory number | |
10325-9 | | Breath rate device Vendor model number | |
10326-7 | | Breath rate device Vendor serial number | |
10830-8 | | Deprecated Surgical operation note complications | |
10831-6 | | Surgical operation note complications [Interpretation] | |
11283-9 | | Acuity assessment [Function] at First encounter | |
11284-7 | | Acuity assessment practitioner identification | |
11285-4 | | Acuity assessment practitioner profession | |
11286-2 | | Alcohol binge episodes per month - Reported | |
11287-0 | | Alcoholic drinks per drinking day - Reported | |
11288-8 | | Arrival time documented | |
11289-6 | | Body temperature at First encounter | |
11290-4 | | Body temperature measurement site at First encounter | |
11291-2 | | Respiratory rate at First encounter | |
11292-0 | | Deprecated Chief complaint: Prid: Pt: ^Patient: Nom: Reported | |
11293-8 | | Type of Referral source | |
11294-6 | | Current employment Narrative - Reported | |
11295-3 | | Current employment - Reported | |
11296-1 | | ED clinical finding practitioner identifier | |
11297-9 | | ED clinical finding practitioner profession | |
11298-7 | | ED consultant practitioner identifier | |
11299-5 | | ED consultant practitioner profession | |
11300-1 | | ED diagnosis | |
11301-9 | | ED diagnosis type | |
11302-7 | | ED discharge disposition | |
11303-5 | | ED disposition consult/referral | |
11304-3 | | ED disposition diagnosis practitioner identification | |
11305-0 | | ED disposition diagnosis practitioner profession | |
11306-8 | | ED medication practitioner identification | |
11307-6 | | ED medication practitioner profession | |
11308-4 | | ED outcome observation practitioner identification | |
11309-2 | | ED outcome observation practitioner profession | |
11310-0 | | ED patient satisfaction report type | |
11311-8 | | ED procedure practitioner profession | |
11312-6 | | ED procedure practitioner identifier | |
11313-4 | | ED procedure result observation [Interpretation] | |
11314-2 | | ED procedure result type | |
11315-9 | | ED service level | |
11316-7 | | ED service level practitioner profession | |
11317-5 | | ED service level practitioner identification | |
11318-3 | | Ambulance transport agency EMS system | |
11319-1 | | Ambulance transport unit [Identifier] EMS system | |
11320-9 | | Feeding and dietary status Narrative - Reported | |
11321-7 | | Feeding and dietary status - Reported | |
11322-5 | | History of General health Narrative | |
11323-3 | | General health - Reported | |
11324-1 | | Glasgow coma score eye opening at First encounter | |
11325-8 | | Glasgow coma score motor at First encounter | |
11326-6 | | Glasgow coma score verbal at First encounter | |
11327-4 | | Heart rate method at First encounter | |
11328-2 | | Heart rate at First encounter | |
11329-0 | | History general Narrative - Reported | |
11330-8 | | History of Alcohol use Narrative | |
11331-6 | | History of Alcohol use | |
11332-4 | | History of Cognitive function Narrative | |
11333-2 | | History of Cognitive function | |
11334-0 | | History of Growth+Development Narrative | |
11335-7 | | History of Growth+Development | |
11336-5 | | History of Hospitalization Narrative | |
11337-3 | | History of Hospitalization | |
11338-1 | | History of Major illnesses and injuries Narrative | |
11339-9 | | History of Major illnesses and injuries | |
11340-7 | | History of Occupation Narrative | |
11341-5 | | History of Occupation | |
11342-3 | | History of Other nonmedical drug use Narrative | |
11343-1 | | History of Other nonmedical drug use | |
11344-9 | | History of Other social factors Narrative | |
11345-6 | | History of Other social factors | |
11346-4 | | History of Outpatient visits Narrative | |
11347-2 | | History of Outpatient visits | |
11348-0 | | History of Past illness Narrative | |
11349-8 | | History of Past illness | |
11350-6 | | History of Sexual behavior Narrative | |
11351-4 | | History of Sexual behavior | |
11352-2 | | History of Allergenic and Immunologic disorders Narrative | |
11353-0 | | History of Breasts disorders Narrative | |
11354-8 | | History of Ears and Nose and Sinuses and Mouth and Throat disorders Narrative | |
11355-5 | | History of Gastrointestinal system disorders Narrative | |
11356-3 | | History of Genitourinary systems disorders Narrative | |
11357-1 | | History of Integumentary system disorders Narrative | |
11358-9 | | History of Psychiatric disorders Narrative | |
11359-7 | | History of Allergenic and Immunologic disorders | |
11360-5 | | History of Breasts disorders | |
11361-3 | | History of Ears and Nose and Sinuses and Mouth and Throat disorders | |
11362-1 | | History of Gastrointestinal system disorders | |
11363-9 | | History of Genitourinary systems disorders | |
11364-7 | | History of Integumentary system disorders | |
11365-4 | | History of Psychiatric disorders | |
11366-2 | | History of Tobacco use Narrative | |
11367-0 | | History of Tobacco use | |
11368-8 | | Illness or injury onset date and time | |
11369-6 | | History of Immunization Narrative | |
11370-4 | | Immunization status - Reported | |
11371-2 | | Initial visit for chief complaint | |
11372-0 | | Injury associated activity | |
11373-8 | | Injury cause | |
11374-6 | | Injury incident description Narrative | |
11375-3 | | Injury intent | |
11376-1 | | Injury location | |
11377-9 | | Diastolic blood pressure at First encounter | |
11378-7 | | Systolic blood pressure at First encounter | |
11379-5 | | Deprecated Highest level of education [Time] - Reported | |
11380-3 | | Marital status and living arrangements Narrative - Reported | |
11381-1 | | Marital status and living arrangements - Reported | |
11382-9 | | Medication allergy - Reported | |
11383-7 | | Patient problem outcome Narrative | |
11384-5 | | Physical examination by organ systems | |
11385-2 | | Physical findings of Ankle Narrative | |
11386-0 | | Physical findings of Upper arm Narrative | |
11387-8 | | Physical findings of Axilla Narrative | |
11388-6 | | Physical findings of Buttocks Narrative | |
11389-4 | | Physical findings of Calf Narrative | |
11390-2 | | Physical findings of Cardiovascular system Narrative | |
11391-0 | | Physical findings of Chest Narrative | |
11392-8 | | Physical findings of Chest wall Narrative | |
11393-6 | | Physical findings of Ears and Nose and Mouth and Throat Narrative | |
11394-4 | | Physical findings of Elbow Narrative | |
11395-1 | | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed | |
11396-9 | | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed | |
11397-7 | | Physical findings of Foot Narrative | |
11398-5 | | Physical findings of Forearm Narrative | |
11399-3 | | Physical findings of Gastrointestinal system Narrative | |
11400-9 | | Physical findings of Genitalia Narrative | |
11401-7 | | Physical findings of Female genitalia Narrative | |
11402-5 | | Physical findings of Male genitalia Narrative | |
11403-3 | | Physical findings of Groin Narrative | |
11404-1 | | Physical findings of Hand Narrative | |
11405-8 | | Deprecated Physical findings: Find: Pt: Heart: Nar: Observed | |
11406-6 | | Physical findings of Hip Narrative | |
11407-4 | | Physical findings of Knee Narrative | |
11408-2 | | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed | |
11409-0 | | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed | |
11410-8 | | Physical findings of Musculoskeletal system Narrative | |
11411-6 | | Physical findings of Neck Narrative | |
11412-4 | | Physical findings of Respiratory system Narrative | |
11413-2 | | Physical findings of Shoulder Narrative | |
11414-0 | | Physical findings of Thigh Narrative | |
11415-7 | | Physical findings of Wrist Narrative | |
11416-5 | | Physical findings of Ankle | |
11417-3 | | Physical findings of Upper arm | |
11418-1 | | Physical findings of Axilla | |
11419-9 | | Physical findings of Buttocks | |
11420-7 | | Physical findings of Calf | |
11421-5 | | Physical findings of Cardiovascular system | |
11422-3 | | Physical findings of Chest | |
11423-1 | | Physical findings of Chest wall | |
11424-9 | | Physical findings of Ears and Nose and Mouth and Throat | |
11425-6 | | Physical findings of Elbow | |
11426-4 | | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed | |
11427-2 | | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed | |
11428-0 | | Physical findings of Foot | |
11429-8 | | Physical findings of Forearm | |
11430-6 | | Physical findings of Gastrointestinal system | |
11431-4 | | Physical findings of Genitalia | |
11432-2 | | Physical findings of Female genitalia | |
11433-0 | | Physical findings of Male genitalia | |
11434-8 | | Physical findings of Groin | |
11435-5 | | Physical findings of Hand | |
11436-3 | | Deprecated Physical findings: Find: Pt: Heart: Nom: Observed | |
11437-1 | | Physical findings of Hip | |
11438-9 | | Physical findings of Knee | |
11439-7 | | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed | |
11440-5 | | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed | |
11441-3 | | Physical findings of Musculoskeletal system | |
11442-1 | | Physical findings of Neck | |
11443-9 | | Physical findings of Respiratory system | |
11444-7 | | Physical findings of Shoulder | |
11445-4 | | Physical findings of Thigh | |
11446-2 | | Physical findings of Wrist | |
11447-0 | | Physical findings of Hematologic and Lymphatic and Immunologic System Narrative | |
11448-8 | | Physical findings of Hematologic and Lymphatic and Immunologic System | |
11449-6 | | Pregnancy status - Reported | |
11450-4 | | Problem list - Reported | |
11451-2 | | Psychiatric findings Narrative | |
11452-0 | | Psychiatric findings | |
11453-8 | | Receiving facility EMS system | |
11454-6 | | Responsiveness assessment at First encounter | |
11455-3 | | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nar: Reported | |
11456-1 | | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nom: Reported | |
11457-9 | | Safety equipment used | |
11458-7 | | Clostridium tetani immunization status | |
11459-5 | | Transport mode EMS system | |
11485-0 | | Anesthesia records | |
11486-8 | | Chemotherapy records | |
11488-4 | | Consult note | |
11490-0 | | Physician Discharge summary | |
11491-6 | | Deprecated Provider-unspecified ED visit note | |
11492-6 | | Provider-unspecifed, History and physical note | |
11493-4 | | Hospital discharge studies summary Narrative | |
11494-2 | | Deprecated Physician Initial assessment note at First encounter | |
11495-9 | | Deprecated Physical therapy Initial assessment note at First encounter | |
11496-7 | | Deprecated Podiatry Initial assessment note at First encounter | |
11497-5 | | Deprecated Psychology Initial assessment note at First encounter | |
11498-3 | | Deprecated Social work Initial assessment note at First encounter | |
11499-1 | | Deprecated Speech therapy Initial assessment note at First encounter | |
11500-6 | | Deprecated Occupational therapy Initial assessment note at First encounter | |
11501-6 | | Deprecated Labor and delivery records | |
11502-2 | | Laboratory report | |
11503-0 | | Medical records | |
11504-8 | | Surgical operation note | |
11505-5 | | Physician procedure note | |
11506-3 | | Progress note | |
11507-1 | | Occupational therapy Progress note | |
11508-9 | | Physical therapy Progress note | |
11509-7 | | Podiatry Progress note | |
11510-5 | | Psychology Progress note | |
11511-3 | | Deprecated Provider-unspecified progress note | |
11512-1 | | Speech-language pathology Progress note | |
11513-9 | | Provider.signing [Identifier] Report | |
11514-7 | | Chiropractic Episode of care medical records | |
11515-4 | | Physical therapy Episode of care medical records | |
11516-2 | | Physician Episode of care medical records | |
11517-0 | | Podiatry Episode of care medical records | |
11518-8 | | Psychology Episode of care medical records | |
11519-6 | | Social service Episode of care medical records | |
11520-4 | | Speech therapy Episode of care medical records | |
11521-2 | | Occupational therapy Episode of care medical records | |
11523-8 | | EEG study | |
11524-6 | | EKG study | |
11525-3 | | US for pregnancy | |
11527-9 | | Psychiatry study | |
11530-3 | | Surgeon.assisting [Identifier] | |
11531-1 | | Surgeon.resident [Identifier] | |
11532-9 | | Surgeon.staff [Identifier] | |
11533-7 | | Surgical drains | |
11534-5 | | Temperature charts | |
11535-2 | | Hospital discharge Dx Narrative | |
11537-8 | | Surgical drains Narrative | |
11543-6 | | Nursery records | |
11544-4 | | Hospital discharge follow-up Narrative | |
11612-9 | | [#] Abortions | |
11613-7 | | [#] Abortions.induced | |
11614-5 | | [#] Abortions.spontaneous | |
11615-2 | | Fetal Heart Activity US | |
11616-0 | | Fetal Heart Narrative Activity US | |
11617-8 | | Fetal Limbs Activity US | |
11618-6 | | Fetal Limbs Narrative Activity US | |
11619-4 | | Fetal Respiratory Activity US | |
11620-2 | | Fetal Respiratory Narrative Activity US | |
11621-0 | | Fetal Trunk Activity US | |
11622-8 | | Fetal Trunk Narrative Activity US | |
11623-6 | | Fetal Quadrant four Amniotic fluid index derived by US | |
11624-4 | | Fetal Quadrant four one Amniotic fluid index derived by US | |
11625-1 | | Fetal Quadrant three Amniotic fluid index derived by US | |
11626-9 | | Fetal Quadrant two Amniotic fluid index derived by US | |
11627-7 | | Fetal Amniotic fluid index.sum derived by US | |
11628-5 | | Fetal Head Binocular distance estimated from Biparietal diameter on US | |
11629-3 | | Fetal Head Binocular distance US | |
11630-1 | | Fetal Biophysical profile.amniotic fluid volume US | |
11631-9 | | Fetal Biophysical profile.body movement US | |
11632-7 | | Fetal Biophysical profile.breathing movement US | |
11633-5 | | Fetal Heart rate reactivity US | |
11634-3 | | Fetal Biophysical profile.sum Derived | |
11635-0 | | Fetal Biophysical profile.tone US | |
11636-8 | | [#] Births.live | |
11637-6 | | [#] Births.preterm | |
11638-4 | | [#] Births.still living | |
11639-2 | | [#] Births.term | |
11640-0 | | [#] Births total | |
11641-8 | | Fetal Mitral valve Peak A wave US.doppler | |
11642-6 | | Deprecated Mitral valve Blood flow.diastolic.atrial wave.max by US.doppler | |
11643-4 | | Fetal Tricuspid valve Peak A wave US.doppler | |
11644-2 | | Deprecated Tricuspid valve Peak A velocity US.doppler | |
11645-9 | | Fetal Mitral valve Peak E wave US.doppler | |
11646-7 | | Deprecated Mitral valve Peak E velocity US.doppler | |
11647-5 | | Fetal Tricuspid valve Peak E wave US.doppler | |
11648-3 | | Deprecated Tricuspid valve Peak E velocity US.doppler | |
11649-1 | | Fetal Mitral valve E-wave/A-wave US.doppler | |
11650-9 | | Deprecated Mitral valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured | |
11651-7 | | Fetal Tricuspid valve E-wave/A-wave US.doppler | |
11652-5 | | Deprecated Tricuspid valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured | |
11653-3 | | Circulatory system End diastolic blood flow velocity US.doppler | |
11654-1 | | Fetal Cerebral artery anterior Minimal flow velocity US.doppler | |
11655-8 | | Cerebral artery anterior Minimal flow velocity US.doppler | |
11656-6 | | Fetal Cerebral artery middle Minimal flow velocity US.doppler | |
11657-4 | | Cerebral artery middle Minimal flow velocity US.doppler | |
11658-2 | | Ovarian artery - left Minimal flow velocity US.doppler | |
11659-0 | | Ovarian artery - right Minimal flow velocity US.doppler | |
11660-8 | | Fetal Umbilical artery at fetus Minimal flow velocity US.doppler | |
11661-6 | | Fetal Umbilical artery at placenta Minimal flow velocity US.doppler | |
11662-4 | | Fetal Umbilical artery between fetus and placenta Minimal flow velocity US.doppler | |
11663-2 | | Uterine artery - left Minimal flow velocity US.doppler | |
11664-0 | | Uterine artery - right Minimal flow velocity US.doppler | |
11665-7 | | Circulatory system Minimal flow velocity US.doppler | |
11666-5 | | Fetal Aorta ascending Mean blood flow velocity US.doppler | |
11667-3 | | Aorta ascending Mean blood flow velocity US.doppler | |
11668-1 | | Fetal Aorta descending Mean blood flow velocity US.doppler | |
11669-9 | | Aorta descending Mean blood flow velocity US.doppler | |
11670-7 | | Fetal Aortic arch Mean blood flow velocity US.doppler | |
11671-5 | | Aortic arch Mean blood flow velocity US.doppler | |
11672-3 | | Fetal Cerebral artery anterior Mean blood flow velocity US.doppler | |
11673-1 | | Cerebral artery anterior Mean blood flow velocity US.doppler | |
11674-9 | | Cerebral artery middle Mean blood flow velocity US.doppler | |
11675-6 | | Fetal Ductus arteriosus Mean blood flow velocity US.doppler | |
11676-4 | | Ductus arteriosus Mean blood flow velocity US.doppler | |
11677-2 | | Fetal Pulmonic valve Mean blood flow velocity US.doppler | |
11678-0 | | Pulmonic valve Mean blood flow velocity by US.doppler | |
11679-8 | | Fetal Left ventricular outflow tract Mean blood flow velocity US.doppler | |
11680-6 | | Deprecated Left ventricular outflow tract Mean blood flow Doppler.measured | |
11681-4 | | Fetal Right ventricular outflow tract Mean blood flow velocity US.doppler | |
11682-2 | | Deprecated Right ventricular outflow tract Mean blood flow Doppler.measured | |
11683-0 | | Ovarian artery - left Mean blood flow velocity US.doppler | |
11684-8 | | Ovarian artery - right Mean blood flow velocity US.doppler | |
11685-5 | | Fetal Main pulmonary artery Mean blood flow velocity US.doppler | |
11686-3 | | Main pulmonary artery Mean blood flow velocity US.doppler | |
11687-1 | | Fetal Umbilical artery at fetus Mean blood flow velocity US.doppler | |
11688-9 | | Fetal Umbilical artery at placenta Mean blood flow US.doppler | |
11689-7 | | Fetal Umbilical artery between fetus and placenta Mean blood flow US.doppler | |
11690-5 | | Uterine artery - left Mean blood flow US.doppler | |
11691-3 | | Uterine artery - right Mean blood flow US.doppler | |
11692-1 | | Circulatory system Maximum blood flow velocity mean US.doppler | |
11693-9 | | Fetal Aorta ascending Peak systolic flow velocity US.doppler | |
11694-7 | | Aorta ascending Peak systolic flow velocity US.doppler | |
11695-4 | | Fetal Aorta descending Peak systolic flow velocity US.doppler | |
11696-2 | | Aorta descending Peak systolic flow velocity US.doppler | |
11697-0 | | Fetal Aortic arch Peak systolic flow velocity US.doppler | |
11698-8 | | Aortic arch Peak systolic flow velocity US.doppler | |
11699-6 | | Fetal Cerebral artery anterior Peak systolic flow velocity US.doppler | |
11700-2 | | Cerebral artery anterior Peak systolic flow velocity US.doppler | |
11701-0 | | Fetal Cerebral artery middle Peak systolic flow velocity US.doppler | |
11702-8 | | Cerebral artery middle Peak systolic flow velocity US.doppler | |
11703-6 | | Fetal Ductus arteriosus Peak systolic flow velocity US.doppler | |
11704-4 | | Ductus arteriosus Peak systolic flow velocity US.doppler | |
11705-1 | | Fetal Aortic valve Peak systolic flow velocity US.doppler | |
11706-9 | | Aortic valve Peak systolic flow by US.doppler | |
11707-7 | | Fetal Mitral valve Peak systolic flow velocity US.doppler | |
11708-5 | | Mitral valve Peak systolic flow velocity by US.doppler | |
11709-3 | | Fetal Pulmonic valve Peak systolic flow velocity US.doppler | |
11710-1 | | Pulmonic valve Peak systolic flow velocity by US.doppler | |
11711-9 | | Fetal Tricuspid valve Peak systolic flow velocity US.doppler | |
11712-7 | | Tricuspid valve Peak systolic flow velocity by US.doppler | |
11713-5 | | Fetal Left ventricular outflow tract Peak systolic flow velocity US.doppler | |
11714-3 | | Deprecated Left ventricular outflow tract Peak systolic flow Doppler.measured | |
11715-0 | | Fetal Right ventricular outflow tract Peak systolic flow velocity US.doppler | |
11716-8 | | Deprecated Right ventricular outflow tract Peak systolic flow Doppler.measured | |
11717-6 | | Ovarian artery - left Peak systolic flow velocity US.doppler | |
11718-4 | | Ovarian artery - right Peak systolic flow velocity US.doppler | |
11719-2 | | Fetal Main pulmonary artery Peak systolic flow velocity US.doppler | |
11720-0 | | Main pulmonary artery Peak systolic flow velocity US.doppler | |
11721-8 | | Fetal Umbilical artery at fetus Peak systolic flow velocity US.doppler | |
11722-6 | | Fetal Umbilical artery at placenta Peak systolic flow velocity US.doppler | |
11723-4 | | Fetal Umbilical artery between fetus and placenta Peak systolic flow velocity US.doppler | |
11724-2 | | Uterine artery - left Peak systolic flow velocity US.doppler | |
11725-9 | | Uterine artery - right Peak systolic flow velocity US.doppler | |
11726-7 | | Circulatory system Peak systolic flow velocity US.doppler | |
11727-5 | | Fetal Body weight estimated by US | |
11728-3 | | Fetal Body weight estimated from Abdominal circumference on US | |
11729-1 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US | |
11730-9 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US | |
11731-7 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US | |
11732-5 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Hadlock 1985 method | |
11733-3 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Roberts 1985 method | |
11734-1 | | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1984 method | |